Frequencies for first 10,000 rows of pt variable in reac2012q4 dataset : 'Preferred Term'-level medical | terminology describing the event | Freq. Percent Cum. ----------------------------------------+----------------------------------- 5-hydroxyindolacetic acid increased | 1 0.01 0.01 ABDOMINAL PAIN UPPER | 1 0.01 0.02 ABSCESS | 1 0.01 0.03 ALANINE AMINOTRANSFERASE INCREASED | 1 0.01 0.04 ALCOHOL USE | 1 0.01 0.05 ALCOHOLIC LIVER DISEASE | 1 0.01 0.06 ANAEMIA | 2 0.02 0.08 ANAPHYLACTOID REACTION | 1 0.01 0.09 ANTINUCLEAR ANTIBODY POSITIVE | 1 0.01 0.10 AORTIC THROMBOSIS | 1 0.01 0.11 ARTHRALGIA | 1 0.01 0.12 ASPARTATE AMINOTRANSFERASE INCREASED | 1 0.01 0.13 ATRIAL FIBRILLATION | 1 0.01 0.14 ATYPICAL MYCOBACTERIAL INFECTION | 1 0.01 0.15 AUTOIMMUNE HEPATITIS | 1 0.01 0.16 Abasia | 16 0.16 0.32 Abdominal abscess | 2 0.02 0.34 Abdominal adhesions | 1 0.01 0.35 Abdominal discomfort | 14 0.14 0.49 Abdominal distension | 23 0.23 0.72 Abdominal hernia | 2 0.02 0.74 Abdominal hernia repair | 1 0.01 0.75 Abdominal neoplasm | 1 0.01 0.76 Abdominal pain | 45 0.45 1.21 Abdominal pain lower | 6 0.06 1.27 Abdominal pain upper | 32 0.32 1.59 Abdominal sepsis | 1 0.01 1.60 Abdominal tenderness | 2 0.02 1.62 Abnormal behaviour | 7 0.07 1.69 Abnormal dreams | 7 0.07 1.76 Abnormal faeces | 1 0.01 1.77 Abnormal sensation in eye | 1 0.01 1.78 Abnormal weight gain | 1 0.01 1.79 Abortion spontaneous | 5 0.05 1.84 Abscess | 5 0.05 1.89 Abscess fungal | 1 0.01 1.90 Abscess intestinal | 2 0.02 1.92 Abscess jaw | 2 0.02 1.94 Accessory cardiac pathway | 1 0.01 1.95 Accident at work | 1 0.01 1.96 Accidental exposure to product by child | 1 0.01 1.97 Accidental overdose | 7 0.07 2.04 Acidosis | 3 0.03 2.07 Acinetobacter infection | 1 0.01 2.08 Acne | 3 0.03 2.11 Acoustic neuroma | 1 0.01 2.12 Activated partial thromboplastin time.. | 2 0.02 2.14 Activities of daily living impaired | 8 0.08 2.22 Acute generalised exanthematous pustu.. | 2 0.02 2.24 Acute graft versus host disease in skin | 1 0.01 2.25 Acute hepatic failure | 2 0.02 2.27 Acute hepatitis B | 1 0.01 2.28 Acute lymphocytic leukaemia | 1 0.01 2.29 Acute lymphocytic leukaemia recurrent | 1 0.01 2.30 Acute myeloid leukaemia | 4 0.04 2.34 Acute myocardial infarction | 8 0.08 2.42 Acute prerenal failure | 1 0.01 2.43 Acute pulmonary oedema | 1 0.01 2.44 Acute respiratory distress syndrome | 7 0.07 2.51 Acute respiratory failure | 7 0.07 2.58 Acute sinusitis | 3 0.03 2.61 Acute tonsillitis | 1 0.01 2.62 Adams-Stokes syndrome | 1 0.01 2.63 Adenocarcinoma gastric | 1 0.01 2.64 Adenocarcinoma pancreas | 1 0.01 2.65 Adenomyosis | 1 0.01 2.66 Adhesion | 1 0.01 2.67 Adjustment disorder | 2 0.02 2.69 Adrenal cyst | 1 0.01 2.70 Adrenal insufficiency | 1 0.01 2.71 Adrenal neoplasm | 1 0.01 2.72 Adult T-cell lymphoma/leukaemia | 1 0.01 2.73 Adverse drug reaction | 1 0.01 2.74 Adverse event | 4 0.04 2.78 Affect lability | 1 0.01 2.79 Affective disorder | 2 0.02 2.81 Age-related macular degeneration | 1 0.01 2.82 Aggression | 7 0.07 2.89 Agitation | 12 0.12 3.01 Agranulocytosis | 4 0.04 3.05 Agraphia | 1 0.01 3.06 Akathisia | 2 0.02 3.08 Alanine aminotransferase increased | 14 0.14 3.22 Alcohol abuse | 1 0.01 3.23 Alcohol withdrawal syndrome | 1 0.01 3.24 Alcoholism | 1 0.01 3.25 Allergy to chemicals | 1 0.01 3.26 Allodynia | 1 0.01 3.27 Alopecia | 31 0.31 3.58 Altered state of consciousness | 5 0.05 3.63 Amaurosis fugax | 1 0.01 3.64 Amenorrhoea | 1 0.01 3.65 Ammonia increased | 3 0.03 3.68 Amnesia | 16 0.16 3.84 Amniotic band syndrome | 1 0.01 3.85 Amylase increased | 2 0.02 3.87 Anaemia | 37 0.37 4.24 Anaemia haemolytic autoimmune | 1 0.01 4.25 Anaemia of chronic disease | 2 0.02 4.27 Anal abscess | 1 0.01 4.28 Anal cancer | 2 0.02 4.30 Anal cancer metastatic | 1 0.01 4.31 Anal fistula | 1 0.01 4.32 Anal haemorrhage | 2 0.02 4.34 Anal pruritus | 1 0.01 4.35 Anal stenosis | 2 0.02 4.37 Analgesic drug level increased | 1 0.01 4.38 Anaphylactic reaction | 3 0.03 4.41 Anaphylactic shock | 3 0.03 4.44 Aneurysm | 1 0.01 4.45 Anger | 6 0.06 4.51 Angina pectoris | 7 0.07 4.58 Angioedema | 2 0.02 4.60 Angiotensin converting enzyme inhibit.. | 1 0.01 4.61 Angle closure glaucoma | 1 0.01 4.62 Anhedonia | 22 0.22 4.84 Animal scratch | 1 0.01 4.85 Anion gap decreased | 1 0.01 4.86 Anisometropia | 1 0.01 4.87 Ankle fracture | 3 0.03 4.90 Ankyloglossia congenital | 1 0.01 4.91 Anomalous pulmonary venous connection | 1 0.01 4.92 Anophthalmos | 1 0.01 4.93 Anorectal disorder | 1 0.01 4.94 Anti-insulin antibody | 1 0.01 4.95 Antinuclear antibody increased | 1 0.01 4.96 Antipsychotic drug level above therap.. | 1 0.01 4.97 Antithrombin III deficiency | 1 0.01 4.98 Anuria | 2 0.02 5.00 Anxiety | 66 0.66 5.66 Anxiety disorder | 1 0.01 5.67 Aorta hypoplasia | 1 0.01 5.68 Aortic aneurysm | 2 0.02 5.70 Aortic arteriosclerosis | 1 0.01 5.71 Aortic calcification | 2 0.02 5.73 Aortic dilatation | 1 0.01 5.74 Aortic dissection | 2 0.02 5.76 Aortic valve calcification | 1 0.01 5.77 Aortic valve disease | 1 0.01 5.78 Aortic valve sclerosis | 2 0.02 5.80 Aortic valve stenosis | 1 0.01 5.81 Aphagia | 6 0.06 5.87 Aphasia | 11 0.11 5.98 Aphonia | 2 0.02 6.00 Aphthous stomatitis | 1 0.01 6.01 Apnoea | 3 0.03 6.04 Appendicectomy | 1 0.01 6.05 Appendicitis | 3 0.03 6.08 Arachnoid cyst | 1 0.01 6.09 Areflexia | 1 0.01 6.10 Arnold-Chiari malformation | 1 0.01 6.11 Arrhythmia | 9 0.09 6.20 Arrhythmia supraventricular | 1 0.01 6.21 Arterial disorder | 1 0.01 6.22 Arterial occlusive disease | 1 0.01 6.23 Arteriosclerosis | 1 0.01 6.24 Arteriosclerosis coronary artery | 6 0.06 6.30 Arteriospasm coronary | 1 0.01 6.31 Arthralgia | 52 0.52 6.83 Arthritis | 12 0.12 6.95 Arthritis bacterial | 1 0.01 6.96 Arthrofibrosis | 1 0.01 6.97 Arthropathy | 10 0.10 7.07 Arthropod bite | 2 0.02 7.09 Ascites | 11 0.11 7.20 Aspartate aminotransferase increased | 13 0.13 7.33 Aspergillosis | 1 0.01 7.34 Aspiration | 1 0.01 7.35 Aspiration pleural cavity | 3 0.03 7.38 Asterixis | 2 0.02 7.40 Asthenia | 76 0.76 8.16 Asthenopia | 1 0.01 8.17 Asthma | 18 0.18 8.35 Asthmatic crisis | 1 0.01 8.36 Ataxia | 4 0.04 8.40 Atelectasis | 9 0.09 8.49 Atelectasis neonatal | 1 0.01 8.50 Atrial fibrillation | 16 0.16 8.66 Atrial flutter | 1 0.01 8.67 Atrial septal defect | 5 0.05 8.72 Atrioventricular block | 3 0.03 8.75 Atrioventricular block first degree | 2 0.02 8.77 Atrioventricular block second degree | 1 0.01 8.78 Atrophic vulvovaginitis | 1 0.01 8.79 Atrophy | 1 0.01 8.80 Atrophy of globe | 1 0.01 8.81 Attention deficit/hyperactivity disor.. | 1 0.01 8.82 Autism | 1 0.01 8.83 Autoimmune hepatitis | 1 0.01 8.84 Autoimmune thyroiditis | 1 0.01 8.85 Axonal neuropathy | 1 0.01 8.86 Azotaemia | 1 0.01 8.87 BACK PAIN | 1 0.01 8.88 BACTERAEMIA | 1 0.01 8.89 BENIGN PROSTATIC HYPERPLASIA | 1 0.01 8.90 BK virus infection | 1 0.01 8.91 BLEEDING VARICOSE VEIN | 1 0.01 8.92 BLOOD POTASSIUM INCREASED | 1 0.01 8.93 BLOOD PRESSURE DIASTOLIC DECREASED | 1 0.01 8.94 BONE PAIN | 1 0.01 8.95 BRONCHIECTASIS | 1 0.01 8.96 Back disorder | 1 0.01 8.97 Back injury | 2 0.02 8.99 Back pain | 58 0.58 9.57 Bacteraemia | 1 0.01 9.58 Bacterial disease carrier | 2 0.02 9.60 Bacterial infection | 7 0.07 9.67 Bacterial sepsis | 1 0.01 9.68 Bacterial test positive | 1 0.01 9.69 Balance disorder | 16 0.16 9.85 Ballismus | 1 0.01 9.86 Barrett's oesophagus | 2 0.02 9.88 Basal cell carcinoma | 2 0.02 9.90 Basal ganglia infarction | 1 0.01 9.91 Base excess increased | 1 0.01 9.92 Bedridden | 1 0.01 9.93 Benign intracranial hypertension | 2 0.02 9.95 Benign neoplasm | 1 0.01 9.96 Benign neoplasm of thyroid gland | 1 0.01 9.97 Bicytopenia | 1 0.01 9.98 Bile duct obstruction | 2 0.02 10.00 Bile duct stenosis | 1 0.01 10.01 Bile duct stone | 2 0.02 10.03 Biliary colic | 1 0.01 10.04 Biliary dyskinesia | 2 0.02 10.06 Bilirubin conjugated increased | 1 0.01 10.07 Bilirubinuria | 1 0.01 10.08 Binocular eye movement disorder | 1 0.01 10.09 Biopsy breast abnormal | 1 0.01 10.10 Bipolar disorder | 5 0.05 10.15 Bladder disorder | 3 0.03 10.18 Bladder spasm | 1 0.01 10.19 Bladder transitional cell carcinoma | 1 0.01 10.20 Blast crisis in myelogenous leukaemia | 3 0.03 10.23 Bleeding time abnormal | 1 0.01 10.24 Bleeding time prolonged | 1 0.01 10.25 Blepharitis | 2 0.02 10.27 Blindness | 13 0.13 10.40 Blindness transient | 1 0.01 10.41 Blindness unilateral | 1 0.01 10.42 Blister | 11 0.11 10.53 Blood albumin decreased | 4 0.04 10.57 Blood alcohol increased | 1 0.01 10.58 Blood alkaline phosphatase | 1 0.01 10.59 Blood alkaline phosphatase increased | 6 0.06 10.65 Blood bicarbonate increased | 1 0.01 10.66 Blood bilirubin increased | 6 0.06 10.72 Blood bilirubin unconjugated increased | 1 0.01 10.73 Blood calcitonin decreased | 1 0.01 10.74 Blood calcium decreased | 11 0.11 10.85 Blood calcium increased | 3 0.03 10.88 Blood chloride decreased | 1 0.01 10.89 Blood chloride increased | 2 0.02 10.91 Blood cholesterol abnormal | 1 0.01 10.92 Blood cholesterol decreased | 2 0.02 10.94 Blood cholesterol increased | 13 0.13 11.07 Blood chromogranin A increased | 1 0.01 11.08 Blood creatine increased | 3 0.03 11.11 Blood creatine phosphokinase MB incre.. | 3 0.03 11.14 Blood creatine phosphokinase increased | 17 0.17 11.31 Blood creatinine decreased | 1 0.01 11.32 Blood creatinine increased | 21 0.21 11.53 Blood culture positive | 3 0.03 11.56 Blood gases abnormal | 2 0.02 11.58 Blood glucose abnormal | 3 0.03 11.61 Blood glucose decreased | 6 0.06 11.67 Blood glucose fluctuation | 3 0.03 11.70 Blood glucose increased | 31 0.31 12.01 Blood growth hormone increased | 1 0.01 12.02 Blood insulin decreased | 1 0.01 12.03 Blood iron decreased | 1 0.01 12.04 Blood lactate dehydrogenase increased | 8 0.08 12.12 Blood lactic acid increased | 1 0.01 12.13 Blood magnesium decreased | 2 0.02 12.15 Blood pH decreased | 1 0.01 12.16 Blood parathyroid hormone increased | 1 0.01 12.17 Blood phosphorus decreased | 2 0.02 12.19 Blood potassium decreased | 7 0.07 12.26 Blood potassium increased | 2 0.02 12.28 Blood pressure | 1 0.01 12.29 Blood pressure abnormal | 3 0.03 12.32 Blood pressure decreased | 19 0.19 12.51 Blood pressure diastolic decreased | 8 0.08 12.59 Blood pressure diastolic increased | 1 0.01 12.60 Blood pressure fluctuation | 2 0.02 12.62 Blood pressure immeasurable | 2 0.02 12.64 Blood pressure inadequately controlled | 1 0.01 12.65 Blood pressure increased | 36 0.36 13.01 Blood pressure systolic increased | 17 0.17 13.18 Blood prolactin increased | 1 0.01 13.19 Blood sodium decreased | 2 0.02 13.21 Blood sodium increased | 1 0.01 13.22 Blood test abnormal | 2 0.02 13.24 Blood testosterone decreased | 1 0.01 13.25 Blood thyroid stimulating hormone inc.. | 2 0.02 13.27 Blood triglycerides increased | 5 0.05 13.32 Blood urea decreased | 1 0.01 13.33 Blood urea increased | 17 0.17 13.50 Blood uric acid increased | 3 0.03 13.53 Blood urine present | 3 0.03 13.56 Bloody discharge | 1 0.01 13.57 Blunted affect | 1 0.01 13.58 Body height decreased | 1 0.01 13.59 Body mass index decreased | 1 0.01 13.60 Body temperature decreased | 3 0.03 13.63 Body temperature increased | 1 0.01 13.64 Bone density decreased | 3 0.03 13.67 Bone development abnormal | 1 0.01 13.68 Bone disorder | 10 0.10 13.78 Bone erosion | 1 0.01 13.79 Bone fistula | 1 0.01 13.80 Bone lesion | 2 0.02 13.82 Bone loss | 1 0.01 13.83 Bone marrow failure | 4 0.04 13.87 Bone pain | 14 0.14 14.01 Bone swelling | 1 0.01 14.02 Bowel movement irregularity | 2 0.02 14.04 Bradyarrhythmia | 1 0.01 14.05 Bradycardia | 12 0.12 14.17 Bradyphrenia | 2 0.02 14.19 Brain herniation | 1 0.01 14.20 Brain hypoxia | 2 0.02 14.22 Brain injury | 2 0.02 14.24 Brain natriuretic peptide increased | 2 0.02 14.26 Brain neoplasm | 2 0.02 14.28 Brain oedema | 5 0.05 14.33 Brain stem stroke | 2 0.02 14.35 Breast calcifications | 1 0.01 14.36 Breast cancer | 14 0.14 14.50 Breast cancer female | 105 1.05 15.55 Breast cancer metastatic | 5 0.05 15.60 Breast cancer recurrent | 3 0.03 15.63 Breast cancer stage II | 2 0.02 15.65 Breast disorder | 1 0.01 15.66 Breast enlargement | 1 0.01 15.67 Breast mass | 1 0.01 15.68 Breast pain | 2 0.02 15.70 Breath holding | 1 0.01 15.71 Breath odour | 1 0.01 15.72 Breath sounds abnormal | 1 0.01 15.73 Bronchial fistula | 1 0.01 15.74 Bronchial hyperreactivity | 1 0.01 15.75 Bronchial wall thickening | 1 0.01 15.76 Bronchiectasis | 1 0.01 15.77 Bronchiolitis | 2 0.02 15.79 Bronchitis | 16 0.16 15.95 Bronchopneumonia | 1 0.01 15.96 Bronchopulmonary aspergillosis | 1 0.01 15.97 Bronchospasm | 1 0.01 15.98 Bruxism | 5 0.05 16.03 Bulimia nervosa | 1 0.01 16.04 Bundle branch block left | 2 0.02 16.06 Burning sensation | 9 0.09 16.15 Bursitis | 1 0.01 16.16 C-reactive protein increased | 8 0.08 16.24 CARDIAC ARREST | 1 0.01 16.25 CARDIAC FAILURE CONGESTIVE | 1 0.01 16.26 CARDIAC MURMUR | 1 0.01 16.27 CARDIOMEGALY | 1 0.01 16.28 CEREBRAL ATROPHY | 1 0.01 16.29 CHEST DISCOMFORT | 1 0.01 16.30 CHEST PAIN | 1 0.01 16.31 CHILLS | 1 0.01 16.32 COGNITIVE DISORDER | 1 0.01 16.33 CONDITION AGGRAVATED | 1 0.01 16.34 CONFUSIONAL STATE | 1 0.01 16.35 CONSTIPATION | 1 0.01 16.36 CSF protein increased | 1 0.01 16.37 CULTURE URINE POSITIVE | 1 0.01 16.38 CUTANEOUS LUPUS ERYTHEMATOSUS | 1 0.01 16.39 Cachexia | 4 0.04 16.43 Caesarean section | 4 0.04 16.47 Calcinosis | 1 0.01 16.48 Calcium deficiency | 1 0.01 16.49 Calcium ionised decreased | 1 0.01 16.50 Calculus ureteric | 1 0.01 16.51 Candidiasis | 3 0.03 16.54 Carcinoid tumour | 1 0.01 16.55 Cardiac arrest | 17 0.17 16.72 Cardiac disorder | 4 0.04 16.76 Cardiac failure | 13 0.13 16.89 Cardiac failure acute | 2 0.02 16.91 Cardiac failure congestive | 7 0.07 16.98 Cardiac flutter | 2 0.02 17.00 Cardiac hypertrophy | 2 0.02 17.02 Cardiac murmur | 6 0.06 17.08 Cardiac septal defect | 1 0.01 17.09 Cardiac stress test abnormal | 1 0.01 17.10 Cardiac tamponade | 1 0.01 17.11 Cardiac valve disease | 3 0.03 17.14 Cardio-respiratory arrest | 3 0.03 17.17 Cardiogenic shock | 3 0.03 17.20 Cardiomegaly | 10 0.10 17.30 Cardiomyopathy | 2 0.02 17.32 Cardiopulmonary failure | 2 0.02 17.34 Cardiovascular disorder | 1 0.01 17.35 Carotid artery occlusion | 1 0.01 17.36 Carotid artery stenosis | 1 0.01 17.37 Carotid artery thrombosis | 1 0.01 17.38 Carpal tunnel decompression | 1 0.01 17.39 Carpal tunnel syndrome | 2 0.02 17.41 Cartilage injury | 1 0.01 17.42 Cataract | 10 0.10 17.52 Catheter site infection | 1 0.01 17.53 Catheter site related reaction | 1 0.01 17.54 Catheterisation cardiac | 3 0.03 17.57 Cellulitis | 16 0.16 17.73 Cellulitis gangrenous | 1 0.01 17.74 Cellulitis orbital | 1 0.01 17.75 Central nervous system lesion | 6 0.06 17.81 Central nervous system lymphoma | 1 0.01 17.82 Central obesity | 1 0.01 17.83 Central venous pressure decreased | 1 0.01 17.84 Cerebellar infarction | 1 0.01 17.85 Cerebellar syndrome | 2 0.02 17.87 Cerebral artery embolism | 1 0.01 17.88 Cerebral artery occlusion | 2 0.02 17.90 Cerebral artery stenosis | 1 0.01 17.91 Cerebral artery thrombosis | 1 0.01 17.92 Cerebral atrophy | 1 0.01 17.93 Cerebral disorder | 1 0.01 17.94 Cerebral haematoma | 1 0.01 17.95 Cerebral haemorrhage | 8 0.08 18.03 Cerebral infarction | 4 0.04 18.07 Cerebral ischaemia | 1 0.01 18.08 Cerebral lobotomy | 1 0.01 18.09 Cerebral thrombosis | 1 0.01 18.10 Cerebral toxoplasmosis | 1 0.01 18.11 Cerebral vasoconstriction | 1 0.01 18.12 Cerebral venous thrombosis | 1 0.01 18.13 Cerebrospinal fluid leakage | 1 0.01 18.14 Cerebrovascular accident | 37 0.37 18.51 Cerebrovascular arteriovenous malform.. | 1 0.01 18.52 Cerebrovascular disorder | 2 0.02 18.54 Cervical dysplasia | 2 0.02 18.56 Cervicitis | 1 0.01 18.57 Chapped lips | 2 0.02 18.59 Cheilitis | 2 0.02 18.61 Chest X-ray abnormal | 2 0.02 18.63 Chest discomfort | 20 0.20 18.83 Chest pain | 53 0.53 19.36 Chest wall mass | 1 0.01 19.37 Chills | 13 0.13 19.50 Choking | 1 0.01 19.51 Choking sensation | 1 0.01 19.52 Cholangitis | 3 0.03 19.55 Cholecystectomy | 3 0.03 19.58 Cholecystitis | 6 0.06 19.64 Cholecystitis acute | 3 0.03 19.67 Cholecystitis chronic | 1 0.01 19.68 Cholecystitis infective | 1 0.01 19.69 Cholelithiasis | 12 0.12 19.81 Cholestasis | 2 0.02 19.83 Cholestatic liver injury | 1 0.01 19.84 Chondropathy | 2 0.02 19.86 Chronic graft versus host disease | 1 0.01 19.87 Chronic lymphocytic leukaemia | 1 0.01 19.88 Chronic myeloid leukaemia | 1 0.01 19.89 Chronic myeloid leukaemia transformat.. | 1 0.01 19.90 Chronic obstructive pulmonary disease | 4 0.04 19.94 Chronic respiratory disease | 1 0.01 19.95 Chronic sinusitis | 1 0.01 19.96 Circulatory collapse | 6 0.06 20.02 Circumstance or information capable o.. | 1 0.01 20.03 Cirrhosis alcoholic | 1 0.01 20.04 Clear cell renal cell carcinoma | 1 0.01 20.05 Cleft lip and palate | 1 0.01 20.06 Cleft palate | 1 0.01 20.07 Clostridium difficile colitis | 2 0.02 20.09 Clostridium difficile infection | 4 0.04 20.13 Clumsiness | 1 0.01 20.14 Coagulopathy | 3 0.03 20.17 Coarctation of the aorta | 2 0.02 20.19 Coccydynia | 1 0.01 20.20 Cognitive disorder | 15 0.15 20.35 Cold sweat | 1 0.01 20.36 Colitis | 4 0.04 20.40 Colitis ischaemic | 1 0.01 20.41 Colitis ulcerative | 6 0.06 20.47 Colon cancer | 3 0.03 20.50 Colon neoplasm | 2 0.02 20.52 Colonoscopy abnormal | 2 0.02 20.54 Colorectal cancer metastatic | 1 0.01 20.55 Colorectal cancer stage I | 1 0.01 20.56 Coma | 11 0.11 20.67 Coma hepatic | 1 0.01 20.68 Coma scale abnormal | 1 0.01 20.69 Communication disorder | 1 0.01 20.70 Community acquired infection | 1 0.01 20.71 Completed suicide | 5 0.05 20.76 Complex regional pain syndrome | 2 0.02 20.78 Complication of delivery | 3 0.03 20.81 Complication of device insertion | 1 0.01 20.82 Complication of device removal | 1 0.01 20.83 Complications of transplanted kidney | 3 0.03 20.86 Compression fracture | 1 0.01 20.87 Compulsive sexual behaviour | 1 0.01 20.88 Computerised tomogram abnormal | 1 0.01 20.89 Concomitant disease progression | 2 0.02 20.91 Concussion | 3 0.03 20.94 Condition aggravated | 20 0.20 21.14 Confusional state | 31 0.31 21.45 Congenital anomaly | 2 0.02 21.47 Congenital central nervous system ano.. | 1 0.01 21.48 Congenital coronary artery malformation | 1 0.01 21.49 Congenital cystic lung | 1 0.01 21.50 Congenital heart valve disorder | 3 0.03 21.53 Congenital pulmonary valve disorder | 1 0.01 21.54 Congestive cardiomyopathy | 2 0.02 21.56 Conjunctival discolouration | 1 0.01 21.57 Conjunctival haemorrhage | 3 0.03 21.60 Conjunctival hyperaemia | 1 0.01 21.61 Conjunctival oedema | 1 0.01 21.62 Conjunctival pallor | 1 0.01 21.63 Conjunctivitis | 3 0.03 21.66 Constipation | 33 0.33 21.99 Contralateral breast cancer | 1 0.01 22.00 Contusion | 14 0.14 22.14 Conversion disorder | 1 0.01 22.15 Convulsion | 28 0.28 22.43 Coordination abnormal | 4 0.04 22.47 Corneal abrasion | 1 0.01 22.48 Corneal deposits | 1 0.01 22.49 Corneal perforation | 1 0.01 22.50 Coronary artery bypass | 2 0.02 22.52 Coronary artery disease | 7 0.07 22.59 Coronary artery occlusion | 4 0.04 22.63 Coronary artery stenosis | 1 0.01 22.64 Coronary artery thrombosis | 1 0.01 22.65 Costovertebral angle tenderness | 1 0.01 22.66 Cough | 41 0.41 23.07 Cranial nerve disorder | 1 0.01 23.08 Craniopharyngioma | 1 0.01 23.09 Creatinine renal clearance decreased | 1 0.01 23.10 Crohn's disease | 8 0.08 23.18 Crush injury | 1 0.01 23.19 Crying | 5 0.05 23.24 Cryoglobulins present | 1 0.01 23.25 Cryptorchism | 2 0.02 23.27 Crystalluria | 1 0.01 23.28 Cubital tunnel syndrome | 1 0.01 23.29 Culture positive | 1 0.01 23.30 Culture wound positive | 1 0.01 23.31 Cutaneous leishmaniasis | 1 0.01 23.32 Cutaneous lupus erythematosus | 1 0.01 23.33 Cutaneous vasculitis | 1 0.01 23.34 Cutis laxa | 1 0.01 23.35 Cyanosis | 9 0.09 23.44 Cyst | 3 0.03 23.47 Cyst rupture | 1 0.01 23.48 Cystitis | 9 0.09 23.57 Cystitis bacterial | 1 0.01 23.58 Cystocele | 1 0.01 23.59 Cytogenetic abnormality | 1 0.01 23.60 Cytomegalovirus hepatitis | 1 0.01 23.61 Cytomegalovirus infection | 3 0.03 23.64 Cytomegalovirus test positive | 1 0.01 23.65 DERMATITIS ATOPIC | 1 0.01 23.66 DIABETES MELLITUS | 1 0.01 23.67 DIZZINESS | 1 0.01 23.68 DNA antibody positive | 1 0.01 23.69 DRUG LEVEL INCREASED | 1 0.01 23.70 DYSPNOEA | 1 0.01 23.71 Dacryostenosis acquired | 1 0.01 23.72 Daydreaming | 1 0.01 23.73 Deafness | 3 0.03 23.76 Deafness neurosensory | 1 0.01 23.77 Deafness unilateral | 2 0.02 23.79 Death | 72 0.72 24.51 Death of relative | 1 0.01 24.52 Decreased activity | 3 0.03 24.55 Decreased appetite | 40 0.40 24.95 Decreased immune responsiveness | 2 0.02 24.97 Decreased interest | 12 0.12 25.09 Decubitus ulcer | 2 0.02 25.11 Deep vein thrombosis | 31 0.31 25.42 Defaecation urgency | 1 0.01 25.43 Deformity | 19 0.19 25.62 Dehydration | 35 0.35 25.97 Delirium | 2 0.02 25.99 Delusion | 3 0.03 26.02 Dementia | 2 0.02 26.04 Dementia Alzheimer's type | 1 0.01 26.05 Demyelination | 2 0.02 26.07 Dengue fever | 1 0.01 26.08 Dental alveolar anomaly | 1 0.01 26.09 Dental care | 1 0.01 26.10 Dental caries | 2 0.02 26.12 Dependence | 1 0.01 26.13 Depressed level of consciousness | 3 0.03 26.16 Depressed mood | 10 0.10 26.26 Depression | 59 0.59 26.85 Depressive symptom | 1 0.01 26.86 Dermal cyst | 1 0.01 26.87 Dermatitis | 6 0.06 26.93 Dermatitis bullous | 3 0.03 26.96 Dermatitis exfoliative | 1 0.01 26.97 Dermatitis infected | 1 0.01 26.98 Developmental delay | 5 0.05 27.03 Device breakage | 2 0.02 27.05 Device component issue | 1 0.01 27.06 Device dislocation | 5 0.05 27.11 Device failure | 1 0.01 27.12 Device leakage | 3 0.03 27.15 Device malfunction | 2 0.02 27.17 Device related infection | 6 0.06 27.23 Device related sepsis | 3 0.03 27.26 Diabetes mellitus | 23 0.23 27.49 Diabetes mellitus inadequate control | 3 0.03 27.52 Diabetic coma | 1 0.01 27.53 Diabetic ketoacidosis | 5 0.05 27.58 Diabetic neuropathy | 1 0.01 27.59 Diabetic retinopathy | 1 0.01 27.60 Dialysis | 1 0.01 27.61 Diaphragmalgia | 1 0.01 27.62 Diarrhoea | 99 0.99 28.61 Diarrhoea infectious | 2 0.02 28.63 Diastolic dysfunction | 2 0.02 28.65 Diastolic hypertension | 1 0.01 28.66 Differential white blood cell count a.. | 1 0.01 28.67 Dihydropyrimidine dehydrogenase defic.. | 1 0.01 28.68 Dilatation ventricular | 1 0.01 28.69 Diphyllobothriasis | 1 0.01 28.70 Diplopia | 5 0.05 28.75 Disability | 12 0.12 28.87 Discomfort | 4 0.04 28.91 Disease progression | 10 0.10 29.01 Disease recurrence | 2 0.02 29.03 Dislocation of vertebra | 1 0.01 29.04 Disorientation | 11 0.11 29.15 Disseminated cytomegaloviral infection | 1 0.01 29.16 Disseminated intravascular coagulation | 9 0.09 29.25 Disseminated tuberculosis | 1 0.01 29.26 Disturbance in attention | 1 0.01 29.27 Diverticulitis | 5 0.05 29.32 Diverticulum | 1 0.01 29.33 Diverticulum intestinal | 3 0.03 29.36 Dizziness | 56 0.56 29.92 Dizziness postural | 1 0.01 29.93 Drug abuse | 4 0.04 29.97 Drug administration error | 5 0.05 30.02 Drug dispensing error | 2 0.02 30.04 Drug dose omission | 16 0.16 30.20 Drug effect decreased | 5 0.05 30.25 Drug effect prolonged | 1 0.01 30.26 Drug eruption | 2 0.02 30.28 Drug hypersensitivity | 10 0.10 30.38 Drug ineffective | 50 0.50 30.88 Drug ineffective for unapproved indic.. | 3 0.03 30.91 Drug interaction | 27 0.27 31.18 Drug intolerance | 2 0.02 31.20 Drug level increased | 3 0.03 31.23 Drug prescribing error | 2 0.02 31.25 Drug reaction with eosinophilia and s.. | 3 0.03 31.28 Drug resistance | 2 0.02 31.30 Drug specific antibody present | 1 0.01 31.31 Drug withdrawal syndrome | 6 0.06 31.37 Drug-induced liver injury | 3 0.03 31.40 Dry eye | 6 0.06 31.46 Dry mouth | 15 0.15 31.61 Dry skin | 9 0.09 31.70 Dry throat | 3 0.03 31.73 Ductus arteriosus premature closure | 1 0.01 31.74 Duodenal ulcer haemorrhage | 3 0.03 31.77 Duodenitis | 3 0.03 31.80 Dysaesthesia | 1 0.01 31.81 Dysarthria | 14 0.14 31.95 Dysgeusia | 12 0.12 32.07 Dysgraphia | 3 0.03 32.10 Dyshidrotic eczema | 1 0.01 32.11 Dyskinesia | 1 0.01 32.12 Dyslipidaemia | 1 0.01 32.13 Dysmenorrhoea | 3 0.03 32.16 Dysmorphism | 1 0.01 32.17 Dyspepsia | 15 0.15 32.32 Dysphagia | 14 0.14 32.46 Dysphemia | 1 0.01 32.47 Dysphonia | 10 0.10 32.57 Dyspnoea | 80 0.80 33.37 Dyspnoea exertional | 7 0.07 33.44 Dyspraxia | 1 0.01 33.45 Dysstasia | 9 0.09 33.54 Dystonia | 1 0.01 33.55 Dysuria | 7 0.07 33.62 ECZEMA HERPETICUM | 1 0.01 33.63 EMPHYSEMA | 1 0.01 33.64 ESCHERICHIA BACTERAEMIA | 1 0.01 33.65 ESSENTIAL TREMOR | 2 0.02 33.67 Ear discomfort | 1 0.01 33.68 Ear haemorrhage | 1 0.01 33.69 Ear infection | 1 0.01 33.70 Ear pain | 6 0.06 33.76 Eating disorder | 6 0.06 33.82 Ecchymosis | 1 0.01 33.83 Eczema | 7 0.07 33.90 Eczema asteatotic | 1 0.01 33.91 Edentulous | 1 0.01 33.92 Ejection fraction decreased | 3 0.03 33.95 Electrocardiogram PR shortened | 1 0.01 33.96 Electrocardiogram QT prolonged | 9 0.09 34.05 Electrocardiogram ST segment elevation | 1 0.01 34.06 Electrocardiogram T wave abnormal | 3 0.03 34.09 Electrocardiogram abnormal | 3 0.03 34.12 Electrocardiogram delta waves abnormal | 1 0.01 34.13 Electroencephalogram abnormal | 1 0.01 34.14 Electrolyte depletion | 1 0.01 34.15 Electrolyte imbalance | 4 0.04 34.19 Embolia cutis medicamentosa | 1 0.01 34.20 Embolism | 2 0.02 34.22 Emotional disorder | 6 0.06 34.28 Emotional distress | 22 0.22 34.50 Emphysema | 4 0.04 34.54 Empyema | 2 0.02 34.56 Encephalitis | 3 0.03 34.59 Encephalitis cytomegalovirus | 1 0.01 34.60 Encephalitis viral | 1 0.01 34.61 Encephalomalacia | 1 0.01 34.62 Encephalopathy | 4 0.04 34.66 Encopresis | 1 0.01 34.67 Endocarditis | 1 0.01 34.68 Endocrine disorder | 1 0.01 34.69 Endometrial hyperplasia | 1 0.01 34.70 Endometriosis | 1 0.01 34.71 Energy increased | 1 0.01 34.72 Engraft failure | 1 0.01 34.73 Enterococcal sepsis | 1 0.01 34.74 Enterocolitis | 2 0.02 34.76 Enterocolitis haemorrhagic | 1 0.01 34.77 Enterovesical fistula | 3 0.03 34.80 Enuresis | 1 0.01 34.81 Enzyme level increased | 1 0.01 34.82 Eosinophil count decreased | 1 0.01 34.83 Eosinophilia | 5 0.05 34.88 Epididymal infection | 1 0.01 34.89 Epidural injection | 1 0.01 34.90 Epigastric discomfort | 2 0.02 34.92 Epilepsy | 3 0.03 34.95 Epistaxis | 10 0.10 35.05 Epstein-Barr viraemia | 1 0.01 35.06 Epstein-Barr virus infection | 3 0.03 35.09 Erectile dysfunction | 8 0.08 35.17 Erosive duodenitis | 1 0.01 35.18 Erosive oesophagitis | 2 0.02 35.20 Eructation | 1 0.01 35.21 Erysipelas | 1 0.01 35.22 Erythema | 16 0.16 35.38 Erythema multiforme | 6 0.06 35.44 Escherichia infection | 1 0.01 35.45 Escherichia urinary tract infection | 1 0.01 35.46 Essential hypertension | 1 0.01 35.47 Euphoric mood | 1 0.01 35.48 Excessive granulation tissue | 1 0.01 35.49 Exercise tolerance decreased | 1 0.01 35.50 Exfoliative rash | 2 0.02 35.52 Exostosis | 4 0.04 35.56 Expired drug administered | 1 0.01 35.57 Exposed bone in jaw | 2 0.02 35.59 Exposure during pregnancy | 12 0.12 35.71 Extrapulmonary tuberculosis | 1 0.01 35.72 Extrapyramidal disorder | 1 0.01 35.73 Extraskeletal ossification | 1 0.01 35.74 Extravasation | 2 0.02 35.76 Extremity contracture | 1 0.01 35.77 Eye disorder | 2 0.02 35.79 Eye haemorrhage | 1 0.01 35.80 Eye infection | 1 0.01 35.81 Eye infection bacterial | 1 0.01 35.82 Eye infection fungal | 1 0.01 35.83 Eye inflammation | 1 0.01 35.84 Eye injury | 1 0.01 35.85 Eye irritation | 3 0.03 35.88 Eye movement disorder | 1 0.01 35.89 Eye oedema | 1 0.01 35.90 Eye pain | 3 0.03 35.93 Eye pruritus | 2 0.02 35.95 Eye swelling | 2 0.02 35.97 Eyelid function disorder | 1 0.01 35.98 Eyelid oedema | 1 0.01 35.99 Eyelid ptosis | 2 0.02 36.01 FALL | 1 0.01 36.02 Face oedema | 3 0.03 36.05 Facial nerve disorder | 1 0.01 36.06 Facial pain | 4 0.04 36.10 Facial paresis | 3 0.03 36.13 Facial wasting | 1 0.01 36.14 Faecal incontinence | 1 0.01 36.15 Faecaloma | 2 0.02 36.17 Faeces discoloured | 2 0.02 36.19 Failure to thrive | 1 0.01 36.20 Fall | 65 0.65 36.85 Fatigue | 112 1.12 37.97 Fear | 16 0.16 38.13 Fear of falling | 1 0.01 38.14 Fear of needles | 1 0.01 38.15 Febrile convulsion | 1 0.01 38.16 Febrile infection | 1 0.01 38.17 Febrile neutropenia | 12 0.12 38.29 Feeding disorder | 2 0.02 38.31 Feeling abnormal | 29 0.29 38.60 Feeling cold | 5 0.05 38.65 Feeling drunk | 2 0.02 38.67 Feeling hot | 6 0.06 38.73 Feeling jittery | 2 0.02 38.75 Feeling of body temperature change | 1 0.01 38.76 Feeling of despair | 1 0.01 38.77 Femoral artery occlusion | 1 0.01 38.78 Femur fracture | 7 0.07 38.85 Fibrin degradation products increased | 1 0.01 38.86 Fibrocystic breast disease | 2 0.02 38.88 Fibromyalgia | 3 0.03 38.91 Fibrosis | 3 0.03 38.94 Fibula fracture | 1 0.01 38.95 Finger deformity | 1 0.01 38.96 Fistula | 1 0.01 38.97 Flank pain | 7 0.07 39.04 Flatulence | 23 0.23 39.27 Fluid intake reduced | 2 0.02 39.29 Fluid overload | 2 0.02 39.31 Fluid retention | 8 0.08 39.39 Flushing | 20 0.20 39.59 Foaming at mouth | 2 0.02 39.61 Foetal distress syndrome | 2 0.02 39.63 Foetal exposure during pregnancy | 16 0.16 39.79 Food allergy | 1 0.01 39.80 Food aversion | 1 0.01 39.81 Food poisoning | 2 0.02 39.83 Foot deformity | 1 0.01 39.84 Foot fracture | 5 0.05 39.89 Fracture | 1 0.01 39.90 Fracture delayed union | 2 0.02 39.92 Fractured sacrum | 1 0.01 39.93 Frequent bowel movements | 5 0.05 39.98 Frustration | 1 0.01 39.99 Full blood count decreased | 2 0.02 40.01 Fungaemia | 1 0.01 40.02 Fungal infection | 3 0.03 40.05 Fungal sepsis | 1 0.01 40.06 GAIT DISTURBANCE | 4 0.04 40.10 GASTRITIS | 1 0.01 40.11 GROIN PAIN | 1 0.01 40.12 Gait disturbance | 44 0.44 40.56 Galactorrhoea | 1 0.01 40.57 Gallbladder cholesterolosis | 1 0.01 40.58 Gallbladder disorder | 3 0.03 40.61 Gamma-glutamyltransferase increased | 7 0.07 40.68 Gangrene | 2 0.02 40.70 Gastric cancer | 1 0.01 40.71 Gastric disorder | 3 0.03 40.74 Gastric haemorrhage | 4 0.04 40.78 Gastric mucosal lesion | 1 0.01 40.79 Gastric perforation | 1 0.01 40.80 Gastric polyps | 2 0.02 40.82 Gastric ulcer | 9 0.09 40.91 Gastric ulcer haemorrhage | 2 0.02 40.93 Gastric varices haemorrhage | 1 0.01 40.94 Gastritis | 11 0.11 41.05 Gastritis erosive | 2 0.02 41.07 Gastritis haemorrhagic | 1 0.01 41.08 Gastroenteritis | 4 0.04 41.12 Gastroenteritis bacterial | 1 0.01 41.13 Gastroenteritis viral | 3 0.03 41.16 Gastrointestinal carcinoma | 2 0.02 41.18 Gastrointestinal disorder | 7 0.07 41.25 Gastrointestinal fistula | 3 0.03 41.28 Gastrointestinal haemorrhage | 21 0.21 41.49 Gastrointestinal infection | 1 0.01 41.50 Gastrointestinal inflammation | 2 0.02 41.52 Gastrointestinal motility disorder | 2 0.02 41.54 Gastrointestinal necrosis | 1 0.01 41.55 Gastrointestinal obstruction | 1 0.01 41.56 Gastrointestinal oedema | 1 0.01 41.57 Gastrointestinal pain | 5 0.05 41.62 Gastrointestinal stoma complication | 1 0.01 41.63 Gastrointestinal stromal tumour | 1 0.01 41.64 Gastrointestinal ulcer | 1 0.01 41.65 Gastrointestinal viral infection | 1 0.01 41.66 Gastrooesophageal reflux disease | 27 0.27 41.93 General physical condition | 1 0.01 41.94 General physical condition abnormal | 1 0.01 41.95 General physical health deterioration | 30 0.30 42.25 General symptom | 2 0.02 42.27 Generalised oedema | 8 0.08 42.35 Genital herpes | 1 0.01 42.36 Genital ulceration | 1 0.01 42.37 Genitourinary tract infection | 1 0.01 42.38 Gestational diabetes | 1 0.01 42.39 Gingival bleeding | 3 0.03 42.42 Gingival disorder | 2 0.02 42.44 Gingival infection | 1 0.01 42.45 Gingival pain | 1 0.01 42.46 Gingival recession | 1 0.01 42.47 Gingival swelling | 3 0.03 42.50 Gingival ulceration | 1 0.01 42.51 Gingivitis | 1 0.01 42.52 Glaucoma | 2 0.02 42.54 Glioblastoma multiforme | 1 0.01 42.55 Glomerular filtration rate decreased | 4 0.04 42.59 Glomerular filtration rate increased | 1 0.01 42.60 Glomerulonephritis proliferative | 1 0.01 42.61 Glossodynia | 2 0.02 42.63 Glucose tolerance impaired | 3 0.03 42.66 Glucose tolerance test abnormal | 1 0.01 42.67 Glycosuria | 1 0.01 42.68 Glycosylated haemoglobin increased | 1 0.01 42.69 Goitre | 2 0.02 42.71 Gout | 5 0.05 42.76 Graft versus host disease | 3 0.03 42.79 Grand mal convulsion | 6 0.06 42.85 Granuloma | 3 0.03 42.88 Granulomatosis with polyangiitis | 1 0.01 42.89 Grip strength decreased | 1 0.01 42.90 Groin abscess | 1 0.01 42.91 Groin pain | 4 0.04 42.95 Growth retardation | 1 0.01 42.96 Guillain-Barre syndrome | 2 0.02 42.98 Gynaecomastia | 1 0.01 42.99 HAEMATOCRIT DECREASED | 1 0.01 43.00 HAEMORRHAGE | 1 0.01 43.01 HEADACHE | 1 0.01 43.02 HEART TRANSPLANT | 1 0.01 43.03 HEPATIC CIRRHOSIS | 1 0.01 43.04 HEPATIC FAILURE | 2 0.02 43.06 HEPATIC FIBROSIS | 1 0.01 43.07 HEPATIC INFARCTION | 1 0.01 43.08 HEPATIC STEATOSIS | 2 0.02 43.10 HEREDITARY ANGIOEDEMA | 1 0.01 43.11 HYPERAMMONAEMIA | 1 0.01 43.12 HYPERNATRAEMIA | 1 0.01 43.13 HYPERPYREXIA | 1 0.01 43.14 HYPERREFLEXIA | 1 0.01 43.15 HYPERTHYROIDISM | 1 0.01 43.16 HYPOGLYCAEMIC COMA | 1 0.01 43.17 HYPOKALAEMIA | 1 0.01 43.18 HYPOPHOSPHATAEMIA | 1 0.01 43.19 HYPOTENSION | 2 0.02 43.21 HYPOTHERMIA | 1 0.01 43.22 HYPOXIA | 1 0.01 43.23 Haematemesis | 9 0.09 43.32 Haematochezia | 15 0.15 43.47 Haematocrit decreased | 8 0.08 43.55 Haematoma | 3 0.03 43.58 Haematospermia | 1 0.01 43.59 Haematuria | 9 0.09 43.68 Haemodialysis | 3 0.03 43.71 Haemodynamic instability | 1 0.01 43.72 Haemoglobin decreased | 30 0.30 44.02 Haemoglobin increased | 1 0.01 44.03 Haemolysis | 1 0.01 44.04 Haemolytic anaemia | 1 0.01 44.05 Haemolytic uraemic syndrome | 1 0.01 44.06 Haemoptysis | 12 0.12 44.18 Haemorrhage | 13 0.13 44.31 Haemorrhage subcutaneous | 1 0.01 44.32 Haemorrhagic diathesis | 2 0.02 44.34 Haemorrhagic stroke | 1 0.01 44.35 Haemorrhoidal haemorrhage | 1 0.01 44.36 Haemorrhoids | 5 0.05 44.41 Haemothorax | 1 0.01 44.42 Hair colour changes | 1 0.01 44.43 Hallucination | 12 0.12 44.55 Hallucination, auditory | 1 0.01 44.56 Hallucination, visual | 2 0.02 44.58 Hallucinations, mixed | 1 0.01 44.59 Hand fracture | 1 0.01 44.60 Hangover | 1 0.01 44.61 Head deformity | 1 0.01 44.62 Head discomfort | 2 0.02 44.64 Head injury | 3 0.03 44.67 Headache | 67 0.67 45.34 Hearing impaired | 3 0.03 45.37 Heart disease congenital | 2 0.02 45.39 Heart rate abnormal | 2 0.02 45.41 Heart rate decreased | 22 0.22 45.63 Heart rate increased | 27 0.27 45.90 Heart rate irregular | 2 0.02 45.92 Heart valve incompetence | 1 0.01 45.93 Helicobacter infection | 2 0.02 45.95 Hemianopia | 1 0.01 45.96 Hemiparesis | 9 0.09 46.05 Hemiplegia | 3 0.03 46.08 Hemivertebra | 1 0.01 46.09 Henoch-Schonlein purpura | 1 0.01 46.10 Hepatic cancer | 4 0.04 46.14 Hepatic cirrhosis | 5 0.05 46.19 Hepatic congestion | 1 0.01 46.20 Hepatic encephalopathy | 7 0.07 46.27 Hepatic enzyme increased | 6 0.06 46.33 Hepatic failure | 13 0.13 46.46 Hepatic fibrosis | 1 0.01 46.47 Hepatic function abnormal | 15 0.15 46.62 Hepatic lesion | 6 0.06 46.68 Hepatic mass | 1 0.01 46.69 Hepatic necrosis | 2 0.02 46.71 Hepatic neoplasm | 3 0.03 46.74 Hepatic pain | 2 0.02 46.76 Hepatic steatosis | 5 0.05 46.81 Hepatitis | 6 0.06 46.87 Hepatitis B | 3 0.03 46.90 Hepatitis B DNA increased | 1 0.01 46.91 Hepatitis C | 3 0.03 46.94 Hepatitis E | 1 0.01 46.95 Hepatitis cholestatic | 5 0.05 47.00 Hepatitis toxic | 1 0.01 47.01 Hepatocellular carcinoma | 1 0.01 47.02 Hepatocellular injury | 1 0.01 47.03 Hepatomegaly | 8 0.08 47.11 Hepatorenal syndrome | 1 0.01 47.12 Hepatosplenomegaly | 3 0.03 47.15 Hernia | 1 0.01 47.16 Hernia obstructive | 2 0.02 47.18 Hernial eventration | 1 0.01 47.19 Herpes simplex | 2 0.02 47.21 Herpes virus infection | 1 0.01 47.22 Herpes zoster | 11 0.11 47.33 Herpes zoster ophthalmic | 1 0.01 47.34 Hiatus hernia | 4 0.04 47.38 Hiccups | 1 0.01 47.39 Hidradenitis | 2 0.02 47.41 High density lipoprotein decreased | 1 0.01 47.42 High risk pregnancy | 1 0.01 47.43 Hilar lymphadenopathy | 2 0.02 47.45 Hip arthroplasty | 3 0.03 47.48 Hip dysplasia | 1 0.01 47.49 Hip fracture | 6 0.06 47.55 Hirsutism | 1 0.01 47.56 Histiocytosis haematophagic | 3 0.03 47.59 Histoplasmosis | 2 0.02 47.61 Hodgkin's disease | 2 0.02 47.63 Hodgkin's disease nodular sclerosis s.. | 1 0.01 47.64 Homicidal ideation | 3 0.03 47.67 Hormone level abnormal | 2 0.02 47.69 Hospitalisation | 6 0.06 47.75 Hot flush | 15 0.15 47.90 Human bite | 1 0.01 47.91 Human herpes virus 6 serology positive | 1 0.01 47.92 Human herpesvirus 7 infection | 1 0.01 47.93 Human papilloma virus test positive | 1 0.01 47.94 Hydrocele | 1 0.01 47.95 Hydrocephalus | 2 0.02 47.97 Hydronephrosis | 5 0.05 48.02 Hydropneumothorax | 1 0.01 48.03 Hyperaesthesia | 1 0.01 48.04 Hyperbilirubinaemia | 2 0.02 48.06 Hypercalcaemia | 1 0.01 48.07 Hyperchlorhydria | 1 0.01 48.08 Hypercholesterolaemia | 3 0.03 48.11 Hypercoagulation | 3 0.03 48.14 Hyperglycaemia | 16 0.16 48.30 Hyperhidrosis | 14 0.14 48.44 Hyperkalaemia | 3 0.03 48.47 Hyperkeratosis | 2 0.02 48.49 Hyperlactacidaemia | 2 0.02 48.51 Hyperlipidaemia | 9 0.09 48.60 Hyperparathyroidism | 1 0.01 48.61 Hyperphagia | 2 0.02 48.63 Hyperpyrexia | 2 0.02 48.65 Hypersensitivity | 22 0.22 48.87 Hypersomnia | 4 0.04 48.91 Hypersplenism | 1 0.01 48.92 Hypertension | 45 0.45 49.37 Hypertensive crisis | 1 0.01 49.38 Hypertensive encephalopathy | 3 0.03 49.41 Hyperthermia | 1 0.01 49.42 Hypertonia | 1 0.01 49.43 Hypertriglyceridaemia | 3 0.03 49.46 Hypertrophic cardiomyopathy | 1 0.01 49.47 Hypertrophic scar | 1 0.01 49.48 Hypertrophy | 1 0.01 49.49 Hyperuricaemia | 1 0.01 49.50 Hypervolaemia | 1 0.01 49.51 Hypoacusis | 7 0.07 49.58 Hypoaesthesia | 40 0.40 49.98 Hypoaesthesia oral | 1 0.01 49.99 Hypoalbuminaemia | 3 0.03 50.02 Hypoaldosteronism | 1 0.01 50.03 Hypocalcaemia | 2 0.02 50.05 Hypochromic anaemia | 2 0.02 50.07 Hypoglycaemia | 10 0.10 50.17 Hypoglycaemia neonatal | 1 0.01 50.18 Hypoglycaemic coma | 1 0.01 50.19 Hypoglycaemic unconsciousness | 1 0.01 50.20 Hypokalaemia | 13 0.13 50.33 Hypokinesia | 8 0.08 50.41 Hyponatraemia | 10 0.10 50.51 Hypoparathyroidism | 1 0.01 50.52 Hypophagia | 7 0.07 50.59 Hypophosphataemia | 3 0.03 50.62 Hypoprothrombinaemia | 1 0.01 50.63 Hyporeflexia | 1 0.01 50.64 Hypotension | 41 0.41 51.05 Hypothermia | 2 0.02 51.07 Hypothyroidism | 5 0.05 51.12 Hypotonia | 2 0.02 51.14 Hypovolaemia | 3 0.03 51.17 Hypovolaemic shock | 1 0.01 51.18 Hypoxia | 8 0.08 51.26 Hysterectomy | 1 0.01 51.27 INFUSION RELATED REACTION | 1 0.01 51.28 INFUSION SITE CELLULITIS | 1 0.01 51.29 INTERSTITIAL LUNG DISEASE | 1 0.01 51.30 IRRITABILITY | 1 0.01 51.31 Idiopathic thrombocytopenic purpura | 1 0.01 51.32 IgA nephropathy | 1 0.01 51.33 Ileal stenosis | 1 0.01 51.34 Ileus | 6 0.06 51.40 Ileus paralytic | 2 0.02 51.42 Ill-defined disorder | 1 0.01 51.43 Immobile | 1 0.01 51.44 Immune reconstitution inflammatory sy.. | 8 0.08 51.52 Immune system disorder | 2 0.02 51.54 Immunodeficiency | 2 0.02 51.56 Immunoglobulins decreased | 1 0.01 51.57 Immunoglobulins increased | 1 0.01 51.58 Immunosuppressant drug level increased | 2 0.02 51.60 Impaired driving ability | 1 0.01 51.61 Impaired gastric emptying | 2 0.02 51.63 Impaired healing | 8 0.08 51.71 Impaired self-care | 1 0.01 51.72 Impetigo | 1 0.01 51.73 Implant site induration | 1 0.01 51.74 Implantable defibrillator insertion | 1 0.01 51.75 Impulsive behaviour | 2 0.02 51.77 Inappropriate affect | 2 0.02 51.79 Inappropriate schedule of drug admini.. | 3 0.03 51.82 Incision site complication | 2 0.02 51.84 Incision site infection | 1 0.01 51.85 Incisional hernia | 1 0.01 51.86 Incontinence | 3 0.03 51.89 Incorrect dose administered | 4 0.04 51.93 Incorrect dose administered by device | 1 0.01 51.94 Incorrect drug administration duration | 1 0.01 51.95 Incorrect route of drug administration | 2 0.02 51.97 Increased appetite | 4 0.04 52.01 Increased tendency to bruise | 4 0.04 52.05 Increased upper airway secretion | 2 0.02 52.07 Induration | 1 0.01 52.08 Infarction | 4 0.04 52.12 Infected skin ulcer | 2 0.02 52.14 Infection | 17 0.17 52.31 Infection in an immunocompromised host | 1 0.01 52.32 Inferior vena cava dilatation | 1 0.01 52.33 Inflammation | 9 0.09 52.42 Inflammatory bowel disease | 4 0.04 52.46 Influenza | 14 0.14 52.60 Influenza like illness | 26 0.26 52.86 Infusion related reaction | 4 0.04 52.90 Infusion site bruising | 1 0.01 52.91 Infusion site cellulitis | 1 0.01 52.92 Infusion site erythema | 1 0.01 52.93 Infusion site pain | 1 0.01 52.94 Infusion site pruritus | 1 0.01 52.95 Infusion site reaction | 1 0.01 52.96 Ingrowing nail | 1 0.01 52.97 Ingrown hair | 1 0.01 52.98 Inguinal hernia | 1 0.01 52.99 Injection site bruising | 5 0.05 53.04 Injection site discomfort | 4 0.04 53.08 Injection site erythema | 4 0.04 53.12 Injection site extravasation | 1 0.01 53.13 Injection site haematoma | 1 0.01 53.14 Injection site haemorrhage | 6 0.06 53.20 Injection site induration | 4 0.04 53.24 Injection site infection | 1 0.01 53.25 Injection site laceration | 1 0.01 53.26 Injection site mass | 4 0.04 53.30 Injection site oedema | 1 0.01 53.31 Injection site pain | 34 0.34 53.65 Injection site pruritus | 5 0.05 53.70 Injection site rash | 2 0.02 53.72 Injection site reaction | 6 0.06 53.78 Injection site scar | 2 0.02 53.80 Injection site swelling | 5 0.05 53.85 Injection site urticaria | 1 0.01 53.86 Injection site warmth | 2 0.02 53.88 Injury | 38 0.38 54.26 Insomnia | 31 0.31 54.57 Insulin-like growth factor decreased | 2 0.02 54.59 Insulin-like growth factor increased | 1 0.01 54.60 Intention tremor | 1 0.01 54.61 Intentional drug misuse | 23 0.23 54.84 Intentional overdose | 5 0.05 54.89 Internal injury | 9 0.09 54.98 International normalised ratio fluctu.. | 1 0.01 54.99 International normalised ratio increa.. | 5 0.05 55.04 Interstitial lung disease | 18 0.18 55.22 Intervertebral disc degeneration | 4 0.04 55.26 Intervertebral disc disorder | 2 0.02 55.28 Intervertebral disc displacement | 1 0.01 55.29 Intervertebral disc protrusion | 10 0.10 55.39 Intervertebral discitis | 1 0.01 55.40 Intestinal gangrene | 1 0.01 55.41 Intestinal infarction | 1 0.01 55.42 Intestinal mass | 1 0.01 55.43 Intestinal obstruction | 14 0.14 55.57 Intestinal perforation | 3 0.03 55.60 Intestinal polyp | 1 0.01 55.61 Intestinal stenosis | 1 0.01 55.62 Intra-aortic balloon placement | 1 0.01 55.63 Intracardiac mass | 1 0.01 55.64 Intracardiac thrombus | 2 0.02 55.66 Intracranial aneurysm | 1 0.01 55.67 Intracranial haematoma | 1 0.01 55.68 Intracranial pressure increased | 1 0.01 55.69 Intracranial venous sinus thrombosis | 1 0.01 55.70 Intraductal proliferative breast lesion | 3 0.03 55.73 Intraocular pressure increased | 3 0.03 55.76 Invasive ductal breast carcinoma | 31 0.31 56.07 Invasive lobular breast carcinoma | 7 0.07 56.14 Iridocyclitis | 1 0.01 56.15 Iris adhesions | 1 0.01 56.16 Iron deficiency anaemia | 2 0.02 56.18 Iron overload | 1 0.01 56.19 Irritability | 3 0.03 56.22 Irritable bowel syndrome | 5 0.05 56.27 Ischaemia | 1 0.01 56.28 Ischaemic cerebral infarction | 3 0.03 56.31 Ischaemic stroke | 4 0.04 56.35 Jaundice | 9 0.09 56.44 Jaundice cholestatic | 4 0.04 56.48 Jaundice neonatal | 2 0.02 56.50 Jaw disorder | 4 0.04 56.54 Jaw fracture | 1 0.01 56.55 Joint ankylosis | 1 0.01 56.56 Joint contracture | 3 0.03 56.59 Joint destruction | 2 0.02 56.61 Joint dislocation | 2 0.02 56.63 Joint effusion | 1 0.01 56.64 Joint injury | 5 0.05 56.69 Joint lock | 1 0.01 56.70 Joint range of motion decreased | 6 0.06 56.76 Joint stiffness | 8 0.08 56.84 Joint swelling | 14 0.14 56.98 Joint warmth | 1 0.01 56.99 Judgement impaired | 1 0.01 57.00 Jugular vein thrombosis | 1 0.01 57.01 Juvenile idiopathic arthritis | 1 0.01 57.02 Juvenile melanoma benign | 1 0.01 57.03 Kaposi's sarcoma | 1 0.01 57.04 Keratitis | 1 0.01 57.05 Kidney enlargement | 2 0.02 57.07 Kidney fibrosis | 1 0.01 57.08 Kidney infection | 3 0.03 57.11 Kidney transplant rejection | 4 0.04 57.15 Klebsiella infection | 1 0.01 57.16 Klebsiella test positive | 1 0.01 57.17 Knee arthroplasty | 3 0.03 57.20 Knee deformity | 1 0.01 57.21 Kounis syndrome | 1 0.01 57.22 Kyphoscoliosis | 1 0.01 57.23 Kyphosis | 2 0.02 57.25 LEFT VENTRICULAR HYPERTROPHY | 1 0.01 57.26 LEUKOCYTOCLASTIC VASCULITIS | 1 0.01 57.27 LOSS OF CONSCIOUSNESS | 2 0.02 57.29 LUMBAR RADICULOPATHY | 1 0.01 57.30 LUNG INFILTRATION | 1 0.01 57.31 Laboratory test interference | 2 0.02 57.33 Laceration | 5 0.05 57.38 Lacrimation increased | 1 0.01 57.39 Lactic acidosis | 2 0.02 57.41 Lacunar infarction | 2 0.02 57.43 Large for dates baby | 2 0.02 57.45 Large intestine perforation | 2 0.02 57.47 Large intestine polyp | 1 0.01 57.48 Laryngeal disorder | 1 0.01 57.49 Laryngitis | 1 0.01 57.50 Laryngomalacia | 2 0.02 57.52 Learning disability | 1 0.01 57.53 Learning disorder | 1 0.01 57.54 Left atrial dilatation | 1 0.01 57.55 Left ventricular dysfunction | 2 0.02 57.57 Left ventricular failure | 1 0.01 57.58 Left ventricular hypertrophy | 1 0.01 57.59 Leg amputation | 1 0.01 57.60 Leiomyoma | 2 0.02 57.62 Lethargy | 7 0.07 57.69 Leukaemia in remission | 1 0.01 57.70 Leukocytoclastic vasculitis | 1 0.01 57.71 Leukocytosis | 7 0.07 57.78 Leukodystrophy | 1 0.01 57.79 Leukopenia | 7 0.07 57.86 Libido decreased | 4 0.04 57.90 Libido increased | 1 0.01 57.91 Life expectancy shortened | 1 0.01 57.92 Ligament injury | 1 0.01 57.93 Ligament rupture | 1 0.01 57.94 Ligament sprain | 2 0.02 57.96 Limb crushing injury | 1 0.01 57.97 Limb discomfort | 4 0.04 58.01 Limb injury | 2 0.02 58.03 Limb operation | 1 0.01 58.04 Lip disorder | 1 0.01 58.05 Lip dry | 1 0.01 58.06 Lip haemorrhage | 1 0.01 58.07 Lip pruritus | 1 0.01 58.08 Lip swelling | 7 0.07 58.15 Lipase increased | 4 0.04 58.19 Lipids decreased | 1 0.01 58.20 Lipids increased | 1 0.01 58.21 Listless | 1 0.01 58.22 Live birth | 1 0.01 58.23 Liver abscess | 1 0.01 58.24 Liver disorder | 10 0.10 58.34 Liver function test abnormal | 9 0.09 58.43 Liver injury | 2 0.02 58.45 Liver transplant rejection | 1 0.01 58.46 Lobar pneumonia | 3 0.03 58.49 Local swelling | 1 0.01 58.50 Localised infection | 5 0.05 58.55 Localised oedema | 1 0.01 58.56 Logorrhoea | 1 0.01 58.57 Loose tooth | 3 0.03 58.60 Lordosis | 1 0.01 58.61 Loss of consciousness | 26 0.26 58.87 Loss of control of legs | 4 0.04 58.91 Loss of libido | 1 0.01 58.92 Low birth weight baby | 3 0.03 58.95 Low density lipoprotein decreased | 1 0.01 58.96 Low turnover osteopathy | 1 0.01 58.97 Lower extremity mass | 1 0.01 58.98 Lower gastrointestinal haemorrhage | 1 0.01 58.99 Lower limb fracture | 1 0.01 59.00 Lower respiratory tract infection | 5 0.05 59.05 Lumbar spinal stenosis | 1 0.01 59.06 Lung abscess | 1 0.01 59.07 Lung adenocarcinoma | 2 0.02 59.09 Lung consolidation | 1 0.01 59.10 Lung disorder | 7 0.07 59.17 Lung hyperinflation | 1 0.01 59.18 Lung infection | 6 0.06 59.24 Lung infiltration | 10 0.10 59.34 Lung infiltration malignant | 1 0.01 59.35 Lung neoplasm malignant | 5 0.05 59.40 Lupus-like syndrome | 1 0.01 59.41 Lymph node palpable | 1 0.01 59.42 Lymphadenitis | 2 0.02 59.44 Lymphadenopathy | 11 0.11 59.55 Lymphocyte count decreased | 5 0.05 59.60 Lymphocyte count increased | 1 0.01 59.61 Lymphocyte morphology abnormal | 1 0.01 59.62 Lymphoedema | 2 0.02 59.64 Lymphoma | 3 0.03 59.67 MEDICAL DEVICE COMPLICATION | 1 0.01 59.68 METABOLIC ACIDOSIS | 1 0.01 59.69 MUSCLE ATROPHY | 1 0.01 59.70 MUSCULAR WEAKNESS | 1 0.01 59.71 Macrocephaly | 1 0.01 59.72 Macrocytosis | 1 0.01 59.73 Macular degeneration | 3 0.03 59.76 Macular fibrosis | 1 0.01 59.77 Macular scar | 1 0.01 59.78 Macule | 1 0.01 59.79 Major depression | 2 0.02 59.81 Malabsorption | 1 0.01 59.82 Malaise | 55 0.55 60.37 Malignant ascites | 1 0.01 60.38 Malignant melanoma | 2 0.02 60.40 Malignant neoplasm progression | 29 0.29 60.69 Malignant pleural effusion | 1 0.01 60.70 Malnutrition | 2 0.02 60.72 Mammogram abnormal | 1 0.01 60.73 Mania | 3 0.03 60.76 Mantle cell lymphoma | 1 0.01 60.77 Marrow hyperplasia | 1 0.01 60.78 Mass | 4 0.04 60.82 Mastectomy | 1 0.01 60.83 Mastication disorder | 2 0.02 60.85 Mastitis | 1 0.01 60.86 Maternal drugs affecting foetus | 3 0.03 60.89 Maternal exposure during pregnancy | 1 0.01 60.90 Mean cell haemoglobin concentration i.. | 1 0.01 60.91 Mean cell haemoglobin decreased | 2 0.02 60.93 Mean cell volume decreased | 1 0.01 60.94 Mean cell volume increased | 1 0.01 60.95 Mean platelet volume decreased | 1 0.01 60.96 Mechanical ventilation | 1 0.01 60.97 Mediastinum neoplasm | 1 0.01 60.98 Medical device complication | 1 0.01 60.99 Medical device pain | 1 0.01 61.00 Medication error | 3 0.03 61.03 Medulloblastoma | 1 0.01 61.04 Megacolon | 1 0.01 61.05 Melaena | 11 0.11 61.16 Melanocytic naevus | 1 0.01 61.17 Melanoma recurrent | 1 0.01 61.18 Memory impairment | 28 0.28 61.46 Meningioma | 2 0.02 61.48 Meningism | 1 0.01 61.49 Meningitis | 2 0.02 61.51 Meningitis meningococcal | 1 0.01 61.52 Meningitis pneumococcal | 1 0.01 61.53 Meningitis viral | 2 0.02 61.55 Meningomyelocele | 1 0.01 61.56 Meniscus injury | 4 0.04 61.60 Menometrorrhagia | 1 0.01 61.61 Menopause | 2 0.02 61.63 Menorrhagia | 3 0.03 61.66 Menstrual disorder | 1 0.01 61.67 Mental disorder | 21 0.21 61.88 Mental impairment | 6 0.06 61.94 Mental status changes | 10 0.10 62.04 Mesenteric vein thrombosis | 1 0.01 62.05 Metabolic acidosis | 10 0.10 62.15 Metabolic syndrome | 2 0.02 62.17 Metamorphopsia | 1 0.01 62.18 Metapneumovirus infection | 1 0.01 62.19 Metastases to abdominal cavity | 1 0.01 62.20 Metastases to bone | 10 0.10 62.30 Metastases to central nervous system | 4 0.04 62.34 Metastases to fallopian tube | 1 0.01 62.35 Metastases to heart | 1 0.01 62.36 Metastases to liver | 10 0.10 62.46 Metastases to lung | 2 0.02 62.48 Metastases to lymph nodes | 1 0.01 62.49 Metastases to ovary | 1 0.01 62.50 Metastases to pancreas | 2 0.02 62.52 Metastases to pelvis | 1 0.01 62.53 Metastases to pleura | 1 0.01 62.54 Metastases to spine | 1 0.01 62.55 Metastases to spleen | 2 0.02 62.57 Metastases to stomach | 1 0.01 62.58 Metastases to uterus | 1 0.01 62.59 Metastatic carcinoid tumour | 1 0.01 62.60 Metastatic lymphoma | 2 0.02 62.62 Metastatic neoplasm | 1 0.01 62.63 Methaemoglobinaemia | 1 0.01 62.64 Metrorrhagia | 1 0.01 62.65 Micturition urgency | 3 0.03 62.68 Middle insomnia | 3 0.03 62.71 Migraine | 18 0.18 62.89 Miosis | 1 0.01 62.90 Mitochondrial toxicity | 1 0.01 62.91 Mitral valve incompetence | 4 0.04 62.95 Mitral valve prolapse | 2 0.02 62.97 Mobility decreased | 16 0.16 63.13 Monocyte count decreased | 1 0.01 63.14 Monocyte count increased | 1 0.01 63.15 Mononeuritis | 1 0.01 63.16 Mood altered | 2 0.02 63.18 Mood swings | 7 0.07 63.25 Moraxella infection | 1 0.01 63.26 Morbid thoughts | 1 0.01 63.27 Morton's neuroma | 1 0.01 63.28 Motor developmental delay | 1 0.01 63.29 Motor dysfunction | 6 0.06 63.35 Mouth haemorrhage | 3 0.03 63.38 Mouth ulceration | 4 0.04 63.42 Mucocutaneous leishmaniasis | 1 0.01 63.43 Mucosal erosion | 1 0.01 63.44 Mucosal haemorrhage | 1 0.01 63.45 Mucosal inflammation | 8 0.08 63.53 Mucosal ulceration | 1 0.01 63.54 Mucous membrane disorder | 9 0.09 63.63 Mucous stools | 1 0.01 63.64 Multi-organ disorder | 1 0.01 63.65 Multi-organ failure | 23 0.23 63.88 Multiple allergies | 1 0.01 63.89 Multiple fractures | 1 0.01 63.90 Multiple sclerosis | 12 0.12 64.02 Multiple sclerosis relapse | 21 0.21 64.23 Murphy's sign positive | 1 0.01 64.24 Muscle atrophy | 7 0.07 64.31 Muscle disorder | 5 0.05 64.36 Muscle fatigue | 1 0.01 64.37 Muscle injury | 2 0.02 64.39 Muscle rigidity | 3 0.03 64.42 Muscle spasms | 24 0.24 64.66 Muscle spasticity | 7 0.07 64.73 Muscle swelling | 2 0.02 64.75 Muscle tightness | 5 0.05 64.80 Muscle twitching | 3 0.03 64.83 Muscular weakness | 28 0.28 65.11 Musculoskeletal chest pain | 2 0.02 65.13 Musculoskeletal discomfort | 2 0.02 65.15 Musculoskeletal disorder | 5 0.05 65.20 Musculoskeletal pain | 19 0.19 65.39 Musculoskeletal stiffness | 14 0.14 65.53 Myalgia | 38 0.38 65.91 Mycosis fungoides | 1 0.01 65.92 Mydriasis | 1 0.01 65.93 Myelitis transverse | 2 0.02 65.95 Myelodysplastic syndrome | 8 0.08 66.03 Myocardial haemorrhage | 1 0.01 66.04 Myocardial infarction | 26 0.26 66.30 Myocardial ischaemia | 2 0.02 66.32 Myoclonus | 1 0.01 66.33 Myoglobin blood increased | 1 0.01 66.34 Myopathy | 4 0.04 66.38 Myositis | 1 0.01 66.39 NEUROLOGICAL SYMPTOM | 1 0.01 66.40 NEUROPATHY PERIPHERAL | 3 0.03 66.43 NEUROTOXICITY | 15 0.15 66.58 NEUTROPENIA | 2 0.02 66.60 NON-SMALL CELL LUNG CANCER | 1 0.01 66.61 Nail avulsion | 1 0.01 66.62 Nail disorder | 10 0.10 66.72 Nail ridging | 1 0.01 66.73 Nasal congestion | 8 0.08 66.81 Nasal discomfort | 1 0.01 66.82 Nasal mucosal disorder | 1 0.01 66.83 Nasal obstruction | 1 0.01 66.84 Nasal septum deviation | 1 0.01 66.85 Nasal sinus cancer | 1 0.01 66.86 Nasal turbinate hypertrophy | 1 0.01 66.87 Nasopharyngitis | 12 0.12 66.99 Nausea | 85 0.85 67.84 Neck injury | 2 0.02 67.86 Neck pain | 11 0.11 67.97 Necrosis | 4 0.04 68.01 Neonatal asphyxia | 2 0.02 68.03 Neonatal cardiac failure | 1 0.01 68.04 Neonatal respiratory arrest | 2 0.02 68.06 Neonatal respiratory depression | 1 0.01 68.07 Neonatal respiratory distress syndrome | 1 0.01 68.08 Neoplasm malignant | 11 0.11 68.19 Neoplasm progression | 8 0.08 68.27 Neoplasm skin | 1 0.01 68.28 Nephritic syndrome | 1 0.01 68.29 Nephritis | 1 0.01 68.30 Nephrogenic systemic fibrosis | 8 0.08 68.38 Nephrolithiasis | 7 0.07 68.45 Nephropathy | 1 0.01 68.46 Nephropathy toxic | 1 0.01 68.47 Nephrotic syndrome | 2 0.02 68.49 Nerve compression | 1 0.01 68.50 Nerve injury | 3 0.03 68.53 Nerve root compression | 1 0.01 68.54 Nervous system disorder | 6 0.06 68.60 Nervousness | 11 0.11 68.71 Neural tube defect | 1 0.01 68.72 Neuralgia | 8 0.08 68.80 Neuritis | 1 0.01 68.81 Neurodegenerative disorder | 1 0.01 68.82 Neurofibroma | 1 0.01 68.83 Neurological symptom | 2 0.02 68.85 Neuropathy peripheral | 13 0.13 68.98 Neurotoxicity | 4 0.04 69.02 Neutropenia | 12 0.12 69.14 Neutropenic sepsis | 1 0.01 69.15 Neutrophil count decreased | 8 0.08 69.23 Neutrophil count increased | 5 0.05 69.28 Neutrophil percentage increased | 1 0.01 69.29 Neutrophilia | 2 0.02 69.31 Night sweats | 5 0.05 69.36 Nightmare | 2 0.02 69.38 No adverse event | 2 0.02 69.40 No therapeutic response | 4 0.04 69.44 Nodule | 2 0.02 69.46 Non-Hodgkin's lymphoma | 3 0.03 69.49 Non-alcoholic steatohepatitis | 1 0.01 69.50 Non-cardiac chest pain | 1 0.01 69.51 Nosocomial infection | 1 0.01 69.52 Nuclear magnetic resonance imaging ab.. | 2 0.02 69.54 Nuclear magnetic resonance imaging br.. | 1 0.01 69.55 Nystagmus | 2 0.02 69.57 OEDEMA PERIPHERAL | 1 0.01 69.58 OPPORTUNISTIC INFECTION | 1 0.01 69.59 ORAL HERPES | 1 0.01 69.60 Obesity | 3 0.03 69.63 Obstruction | 2 0.02 69.65 Occult blood positive | 2 0.02 69.67 Ocular hyperaemia | 3 0.03 69.70 Ocular vasculitis | 1 0.01 69.71 Odynophagia | 2 0.02 69.73 Oedema | 9 0.09 69.82 Oedema mouth | 1 0.01 69.83 Oedema peripheral | 56 0.56 70.39 Oesophageal candidiasis | 1 0.01 70.40 Oesophageal disorder | 1 0.01 70.41 Oesophageal pain | 2 0.02 70.43 Oesophageal stenosis | 1 0.01 70.44 Oesophageal ulcer | 2 0.02 70.46 Oesophageal varices haemorrhage | 1 0.01 70.47 Oesophagitis | 7 0.07 70.54 Oestrogen receptor assay positive | 3 0.03 70.57 Off label use | 24 0.24 70.81 Oligomenorrhoea | 2 0.02 70.83 Oliguria | 4 0.04 70.87 Onychoclasis | 1 0.01 70.88 Onychogryphosis | 1 0.01 70.89 Onychomadesis | 1 0.01 70.90 Onychomycosis | 4 0.04 70.94 Optic nerve disorder | 1 0.01 70.95 Optic nerve hypoplasia | 1 0.01 70.96 Optic neuritis | 2 0.02 70.98 Oral candidiasis | 5 0.05 71.03 Oral cavity fistula | 1 0.01 71.04 Oral disorder | 2 0.02 71.06 Oral herpes | 4 0.04 71.10 Oral infection | 2 0.02 71.12 Oral mucosa erosion | 1 0.01 71.13 Oral mucosal blistering | 3 0.03 71.16 Oral pain | 3 0.03 71.19 Organising pneumonia | 3 0.03 71.22 Oropharyngeal blistering | 1 0.01 71.23 Oropharyngeal pain | 12 0.12 71.35 Orthopnoea | 1 0.01 71.36 Orthostatic hypotension | 2 0.02 71.38 Osteoarthritis | 14 0.14 71.52 Osteolysis | 2 0.02 71.54 Osteomyelitis | 4 0.04 71.58 Osteomyelitis chronic | 1 0.01 71.59 Osteonecrosis | 7 0.07 71.66 Osteonecrosis of jaw | 13 0.13 71.79 Osteopenia | 5 0.05 71.84 Osteoporosis | 6 0.06 71.90 Osteoporotic fracture | 1 0.01 71.91 Osteoradionecrosis | 1 0.01 71.92 Osteosclerosis | 1 0.01 71.93 Otitis externa | 1 0.01 71.94 Otitis media | 1 0.01 71.95 Otitis media chronic | 1 0.01 71.96 Otorrhoea | 1 0.01 71.97 Ototoxicity | 1 0.01 71.98 Ovarian cancer | 2 0.02 72.00 Ovarian cyst | 3 0.03 72.03 Overdose | 16 0.16 72.19 Oxygen consumption decreased | 1 0.01 72.20 Oxygen saturation decreased | 5 0.05 72.25 PLATELET COUNT DECREASED | 1 0.01 72.26 PLEURAL EFFUSION | 3 0.03 72.29 PLEURITIC PAIN | 1 0.01 72.30 PNEUMONIA | 1 0.01 72.31 PORTAL HYPERTENSION | 1 0.01 72.32 PSEUDOMONAL SEPSIS | 1 0.01 72.33 PULMONARY ARTERIAL WEDGE PRESSURE INC.. | 1 0.01 72.34 PULMONARY HYPERTENSION | 1 0.01 72.35 Pain | 125 1.25 73.60 Pain in extremity | 67 0.67 74.27 Pain in jaw | 4 0.04 74.31 Pain of skin | 1 0.01 74.32 Painful defaecation | 1 0.01 74.33 Pallor | 6 0.06 74.39 Palmar-plantar erythrodysaesthesia sy.. | 11 0.11 74.50 Palpitations | 16 0.16 74.66 Pancreatic carcinoma | 4 0.04 74.70 Pancreatic enzymes increased | 1 0.01 74.71 Pancreatic neoplasm | 1 0.01 74.72 Pancreatic pseudocyst | 1 0.01 74.73 Pancreatitis | 15 0.15 74.88 Pancreatitis acute | 9 0.09 74.97 Pancreatitis chronic | 1 0.01 74.98 Pancreatitis necrotising | 1 0.01 74.99 Pancreatitis relapsing | 1 0.01 75.00 Pancytopenia | 5 0.05 75.05 Panic attack | 7 0.07 75.12 Panic disorder | 1 0.01 75.13 Panophthalmitis | 1 0.01 75.14 Papillary thyroid cancer | 1 0.01 75.15 Papilloedema | 2 0.02 75.17 Paracentesis | 2 0.02 75.19 Paraesthesia | 11 0.11 75.30 Paraesthesia oral | 1 0.01 75.31 Parakeratosis | 1 0.01 75.32 Paralysis | 2 0.02 75.34 Paralysis flaccid | 1 0.01 75.35 Paraneoplastic syndrome | 1 0.01 75.36 Paranoia | 4 0.04 75.40 Paraparesis | 1 0.01 75.41 Paraplegia | 3 0.03 75.44 Paraproteinaemia | 2 0.02 75.46 Paresis | 1 0.01 75.47 Parosmia | 1 0.01 75.48 Parotid abscess | 1 0.01 75.49 Parotid gland enlargement | 1 0.01 75.50 Parotitis | 2 0.02 75.52 Paroxysmal perceptual alteration | 1 0.01 75.53 Partial seizures with secondary gener.. | 1 0.01 75.54 Patella fracture | 2 0.02 75.56 Patent ductus arteriosus | 2 0.02 75.58 Pathological fracture | 2 0.02 75.60 Pathological gambling | 2 0.02 75.62 Peau d'orange | 1 0.01 75.63 Pectus carinatum | 1 0.01 75.64 Pelvic abscess | 2 0.02 75.66 Pelvic discomfort | 1 0.01 75.67 Pelvic fracture | 1 0.01 75.68 Pelvic haematoma | 1 0.01 75.69 Pelvic neoplasm | 1 0.01 75.70 Pelvic pain | 2 0.02 75.72 Pelvic venous thrombosis | 3 0.03 75.75 Peptic ulcer | 1 0.01 75.76 Periarthritis | 3 0.03 75.79 Pericardial cyst | 1 0.01 75.80 Pericardial effusion | 6 0.06 75.86 Pericardial haemorrhage | 1 0.01 75.87 Pericarditis | 1 0.01 75.88 Pericolic abscess | 1 0.01 75.89 Perineal abscess | 1 0.01 75.90 Periodontal disease | 2 0.02 75.92 Periodontitis | 2 0.02 75.94 Periorbital oedema | 3 0.03 75.97 Peripheral T-cell lymphoma unspecified | 1 0.01 75.98 Peripheral arterial occlusive disease | 3 0.03 76.01 Peripheral artery stenosis | 1 0.01 76.02 Peripheral artery thrombosis | 2 0.02 76.04 Peripheral coldness | 2 0.02 76.06 Peripheral ischaemia | 1 0.01 76.07 Peripheral paralysis | 1 0.01 76.08 Peripheral sensory neuropathy | 1 0.01 76.09 Perirectal abscess | 2 0.02 76.11 Peritoneal dialysis | 1 0.01 76.12 Peritoneal lesion | 1 0.01 76.13 Peritonitis | 5 0.05 76.18 Peritonitis bacterial | 1 0.01 76.19 Perivascular dermatitis | 1 0.01 76.20 Periventricular nodular heterotopia | 1 0.01 76.21 Peroneal nerve palsy | 1 0.01 76.22 Personality change | 2 0.02 76.24 Pertussis | 1 0.01 76.25 Petechiae | 2 0.02 76.27 Petit mal epilepsy | 5 0.05 76.32 Pharyngeal erythema | 1 0.01 76.33 Pharyngeal mass | 2 0.02 76.35 Pharyngeal neoplasm | 1 0.01 76.36 Pharyngeal oedema | 2 0.02 76.38 Pharyngeal ulceration | 1 0.01 76.39 Pharyngitis | 2 0.02 76.41 Pharyngitis streptococcal | 1 0.01 76.42 Phlebitis | 4 0.04 76.46 Phobia | 1 0.01 76.47 Photodermatosis | 2 0.02 76.49 Photophobia | 1 0.01 76.50 Photopsia | 1 0.01 76.51 Photosensitivity reaction | 1 0.01 76.52 Phrenic nerve paralysis | 1 0.01 76.53 Physical assault | 3 0.03 76.56 Physical disability | 2 0.02 76.58 Pigmentation disorder | 10 0.10 76.68 Pituitary tumour | 2 0.02 76.70 Pituitary tumour benign | 1 0.01 76.71 Placental insufficiency | 1 0.01 76.72 Plantar fasciitis | 2 0.02 76.74 Plasma cell myeloma | 3 0.03 76.77 Plasmacytoma | 1 0.01 76.78 Platelet aggregation abnormal | 1 0.01 76.79 Platelet count decreased | 23 0.23 77.02 Platelet count increased | 3 0.03 77.05 Platelet disorder | 1 0.01 77.06 Pleural effusion | 28 0.28 77.34 Pleurisy | 2 0.02 77.36 Pleuritic pain | 4 0.04 77.40 Pneumocystis jiroveci pneumonia | 11 0.11 77.51 Pneumonia | 47 0.47 77.98 Pneumonia aspiration | 9 0.09 78.07 Pneumonia bacterial | 2 0.02 78.09 Pneumonia cytomegaloviral | 1 0.01 78.10 Pneumonia pneumococcal | 2 0.02 78.12 Pneumonia staphylococcal | 2 0.02 78.14 Pneumonia viral | 1 0.01 78.15 Pneumonitis | 5 0.05 78.20 Pneumothorax | 3 0.03 78.23 Poisoning | 1 0.01 78.24 Pollakiuria | 7 0.07 78.31 Polyarthritis | 1 0.01 78.32 Polycystic ovaries | 1 0.01 78.33 Polydipsia | 2 0.02 78.35 Polymenorrhoea | 1 0.01 78.36 Polymyalgia rheumatica | 2 0.02 78.38 Polymyositis | 2 0.02 78.40 Polyneuropathy | 1 0.01 78.41 Polyuria | 1 0.01 78.42 Poor quality drug administered | 1 0.01 78.43 Poor quality sleep | 1 0.01 78.44 Poor venous access | 4 0.04 78.48 Portal hypertension | 1 0.01 78.49 Portal vein thrombosis | 3 0.03 78.52 Post lumbar puncture syndrome | 1 0.01 78.53 Post procedural complication | 5 0.05 78.58 Post procedural haemorrhage | 1 0.01 78.59 Post procedural pneumonia | 1 0.01 78.60 Post thrombotic syndrome | 2 0.02 78.62 Post transplant lymphoproliferative d.. | 2 0.02 78.64 Post-traumatic amnestic disorder | 1 0.01 78.65 Post-traumatic pain | 1 0.01 78.66 Post-traumatic stress disorder | 2 0.02 78.68 Posterior reversible encephalopathy s.. | 1 0.01 78.69 Postmenopausal haemorrhage | 2 0.02 78.71 Postoperative ileus | 1 0.01 78.72 Postoperative wound infection | 1 0.01 78.73 Posture abnormal | 1 0.01 78.74 Pre-eclampsia | 1 0.01 78.75 Precancerous cells present | 1 0.01 78.76 Pregnancy | 3 0.03 78.79 Pregnancy on oral contraceptive | 1 0.01 78.80 Pregnancy with contraceptive device | 2 0.02 78.82 Premature baby | 9 0.09 78.91 Premature delivery | 2 0.02 78.93 Premature labour | 1 0.01 78.94 Presyncope | 3 0.03 78.97 Primary sequestrum | 3 0.03 79.00 Procedural complication | 1 0.01 79.01 Procedural pain | 4 0.04 79.05 Proctalgia | 2 0.02 79.07 Product contamination | 1 0.01 79.08 Product quality issue | 5 0.05 79.13 Productive cough | 6 0.06 79.19 Progesterone receptor assay positive | 3 0.03 79.22 Progressive multifocal leukoencephalo.. | 7 0.07 79.29 Prostate cancer metastatic | 1 0.01 79.30 Prostatic specific antigen increased | 4 0.04 79.34 Prostatomegaly | 2 0.02 79.36 Protein total decreased | 3 0.03 79.39 Protein urine present | 2 0.02 79.41 Proteinuria | 2 0.02 79.43 Prothrombin time prolonged | 3 0.03 79.46 Pruritus | 28 0.28 79.74 Pruritus allergic | 1 0.01 79.75 Pruritus generalised | 1 0.01 79.76 Pseudarthrosis | 1 0.01 79.77 Pseudomembranous colitis | 2 0.02 79.79 Pseudomonas infection | 1 0.01 79.80 Psoriasis | 8 0.08 79.88 Psoriatic arthropathy | 1 0.01 79.89 Psychogenic seizure | 1 0.01 79.90 Psychological trauma | 1 0.01 79.91 Psychomotor hyperactivity | 2 0.02 79.93 Psychomotor retardation | 1 0.01 79.94 Psychotic behaviour | 1 0.01 79.95 Psychotic disorder | 4 0.04 79.99 Pubis fracture | 1 0.01 80.00 Pulmonary alveolar haemorrhage | 1 0.01 80.01 Pulmonary cavitation | 1 0.01 80.02 Pulmonary congestion | 1 0.01 80.03 Pulmonary embolism | 48 0.48 80.51 Pulmonary fibrosis | 1 0.01 80.52 Pulmonary function test decreased | 1 0.01 80.53 Pulmonary haemorrhage | 3 0.03 80.56 Pulmonary hilum mass | 1 0.01 80.57 Pulmonary hypertension | 5 0.05 80.62 Pulmonary infarction | 3 0.03 80.65 Pulmonary mass | 7 0.07 80.72 Pulmonary mycosis | 1 0.01 80.73 Pulmonary necrosis | 1 0.01 80.74 Pulmonary oedema | 7 0.07 80.81 Pulmonary sepsis | 1 0.01 80.82 Pulmonary tuberculosis | 6 0.06 80.88 Pulmonary valve incompetence | 2 0.02 80.90 Pulmonary valve sclerosis | 2 0.02 80.92 Pulse absent | 1 0.01 80.93 Pupillary reflex impaired | 2 0.02 80.95 Pupils unequal | 1 0.01 80.96 Purpura | 2 0.02 80.98 Purulent discharge | 2 0.02 81.00 Pyelonephritis | 6 0.06 81.06 Pyelonephritis chronic | 1 0.01 81.07 Pyrexia | 75 0.75 81.82 Pyuria | 1 0.01 81.83 QRS axis abnormal | 1 0.01 81.84 Quadriplegia | 1 0.01 81.85 Quality of life decreased | 5 0.05 81.90 RADICULOPATHY | 1 0.01 81.91 RESPIRATORY FAILURE | 1 0.01 81.92 RESTRICTIVE PULMONARY DISEASE | 1 0.01 81.93 RHABDOMYOLYSIS | 1 0.01 81.94 Radial nerve palsy | 1 0.01 81.95 Radiculopathy | 3 0.03 81.98 Radius fracture | 1 0.01 81.99 Rales | 2 0.02 82.01 Rash | 36 0.36 82.37 Rash erythematous | 4 0.04 82.41 Rash generalised | 5 0.05 82.46 Rash macular | 2 0.02 82.48 Rash maculo-papular | 5 0.05 82.53 Rash papular | 2 0.02 82.55 Rash pruritic | 4 0.04 82.59 Rash pustular | 2 0.02 82.61 Raynaud's phenomenon | 2 0.02 82.63 Reaction to preservatives | 1 0.01 82.64 Reading disorder | 1 0.01 82.65 Rectal abscess | 1 0.01 82.66 Rectal cancer | 1 0.01 82.67 Rectal haemorrhage | 9 0.09 82.76 Rectal polyp | 1 0.01 82.77 Rectal stenosis | 1 0.01 82.78 Rectocele | 2 0.02 82.80 Red blood cell count decreased | 14 0.14 82.94 Red blood cell sedimentation rate inc.. | 3 0.03 82.97 Red cell distribution width increased | 6 0.06 83.03 Refusal of treatment by patient | 1 0.01 83.04 Renal abscess | 1 0.01 83.05 Renal artery stenosis | 1 0.01 83.06 Renal atrophy | 1 0.01 83.07 Renal cancer | 2 0.02 83.09 Renal cyst | 2 0.02 83.11 Renal disorder | 5 0.05 83.16 Renal failure | 37 0.37 83.53 Renal failure acute | 35 0.35 83.88 Renal failure chronic | 3 0.03 83.91 Renal impairment | 26 0.26 84.17 Renal injury | 9 0.09 84.26 Renal pain | 1 0.01 84.27 Renal transplant | 1 0.01 84.28 Renal tubular atrophy | 1 0.01 84.29 Renal tubular disorder | 2 0.02 84.31 Renal tubular necrosis | 4 0.04 84.35 Respiratory acidosis | 1 0.01 84.36 Respiratory arrest | 3 0.03 84.39 Respiratory depression | 3 0.03 84.42 Respiratory disorder | 7 0.07 84.49 Respiratory distress | 9 0.09 84.58 Respiratory failure | 22 0.22 84.80 Respiratory rate increased | 2 0.02 84.82 Respiratory tract congestion | 3 0.03 84.85 Respiratory tract haemorrhage | 1 0.01 84.86 Respiratory tract infection | 3 0.03 84.89 Respiratory tract infection fungal | 1 0.01 84.90 Respiratory tract oedema | 1 0.01 84.91 Restless legs syndrome | 3 0.03 84.94 Restlessness | 5 0.05 84.99 Resuscitation | 1 0.01 85.00 Retching | 2 0.02 85.02 Retinal artery occlusion | 5 0.05 85.07 Retinal haemorrhage | 2 0.02 85.09 Retinal vascular occlusion | 1 0.01 85.10 Retinal vein occlusion | 3 0.03 85.13 Retroperitoneal abscess | 2 0.02 85.15 Retroperitoneal haematoma | 1 0.01 85.16 Retroperitoneal haemorrhage | 3 0.03 85.19 Retroperitoneal lymphadenopathy | 1 0.01 85.20 Rhabdomyolysis | 9 0.09 85.29 Rheumatoid arthritis | 4 0.04 85.33 Rhinitis | 3 0.03 85.36 Rhinitis allergic | 2 0.02 85.38 Rhinorrhoea | 5 0.05 85.43 Rib fracture | 5 0.05 85.48 Right aortic arch | 1 0.01 85.49 Right atrial dilatation | 1 0.01 85.50 Right atrial pressure increased | 1 0.01 85.51 Right ventricular dysfunction | 1 0.01 85.52 Right ventricular failure | 1 0.01 85.53 Right ventricular hypertrophy | 1 0.01 85.54 Right ventricular systolic pressure d.. | 1 0.01 85.55 Road traffic accident | 8 0.08 85.63 Romberg test positive | 1 0.01 85.64 Rosacea | 1 0.01 85.65 Rotator cuff repair | 1 0.01 85.66 Rotator cuff syndrome | 10 0.10 85.76 Ruptured cerebral aneurysm | 1 0.01 85.77 SELF-MEDICATION | 1 0.01 85.78 SEPSIS | 3 0.03 85.81 SHOCK | 1 0.01 85.82 SPLENIC INFARCTION | 1 0.01 85.83 STEVENS-JOHNSON SYNDROME | 1 0.01 85.84 SYNCOPE | 1 0.01 85.85 Sacroiliitis | 1 0.01 85.86 Salivary gland disorder | 1 0.01 85.87 Salivary gland enlargement | 1 0.01 85.88 Scab | 1 0.01 85.89 Scar | 16 0.16 86.05 Schizophrenia | 6 0.06 86.11 Schizophrenia, paranoid type | 2 0.02 86.13 Sciatica | 5 0.05 86.18 Scleral discolouration | 1 0.01 86.19 Sclerema | 1 0.01 86.20 Sclerodactylia | 1 0.01 86.21 Scoliosis | 4 0.04 86.25 Scratch | 1 0.01 86.26 Screaming | 1 0.01 86.27 Scrotal infection | 1 0.01 86.28 Scrotal pain | 1 0.01 86.29 Seasonal allergy | 1 0.01 86.30 Seborrhoeic dermatitis | 1 0.01 86.31 Second primary malignancy | 8 0.08 86.39 Secondary progressive multiple sclero.. | 2 0.02 86.41 Secretion discharge | 1 0.01 86.42 Sedation | 3 0.03 86.45 Selective abortion | 1 0.01 86.46 Self injurious behaviour | 1 0.01 86.47 Semen volume decreased | 1 0.01 86.48 Sensation of heaviness | 1 0.01 86.49 Sensation of pressure | 1 0.01 86.50 Sensitivity of teeth | 1 0.01 86.51 Sensory disturbance | 5 0.05 86.56 Sensory loss | 1 0.01 86.57 Sepsis | 29 0.29 86.86 Sepsis neonatal | 1 0.01 86.87 Septic shock | 11 0.11 86.98 Seroma | 2 0.02 87.00 Serositis | 1 0.01 87.01 Serotonin syndrome | 2 0.02 87.03 Serratia infection | 1 0.01 87.04 Serum ferritin decreased | 1 0.01 87.05 Serum ferritin increased | 5 0.05 87.10 Serum serotonin increased | 1 0.01 87.11 Serum sickness | 2 0.02 87.13 Sexual dysfunction | 1 0.01 87.14 Shock | 4 0.04 87.18 Shock haemorrhagic | 1 0.01 87.19 Shock hypoglycaemic | 1 0.01 87.20 Shoulder arthroplasty | 1 0.01 87.21 Shunt infection | 1 0.01 87.22 Sick sinus syndrome | 1 0.01 87.23 Simple partial seizures | 1 0.01 87.24 Sinus bradycardia | 3 0.03 87.27 Sinus congestion | 2 0.02 87.29 Sinus disorder | 3 0.03 87.32 Sinus tachycardia | 6 0.06 87.38 Sinusitis | 20 0.20 87.58 Skeletal injury | 1 0.01 87.59 Skin atrophy | 4 0.04 87.63 Skin burning sensation | 8 0.08 87.71 Skin cancer | 1 0.01 87.72 Skin discolouration | 17 0.17 87.89 Skin disorder | 5 0.05 87.94 Skin exfoliation | 18 0.18 88.12 Skin fibrosis | 2 0.02 88.14 Skin fissures | 3 0.03 88.17 Skin haemorrhage | 2 0.02 88.19 Skin hyperpigmentation | 3 0.03 88.22 Skin hypertrophy | 7 0.07 88.29 Skin hypopigmentation | 1 0.01 88.30 Skin induration | 6 0.06 88.36 Skin infection | 2 0.02 88.38 Skin injury | 1 0.01 88.39 Skin irritation | 1 0.01 88.40 Skin lesion | 12 0.12 88.52 Skin mass | 1 0.01 88.53 Skin necrosis | 4 0.04 88.57 Skin oedema | 1 0.01 88.58 Skin plaque | 4 0.04 88.62 Skin sensitisation | 1 0.01 88.63 Skin swelling | 1 0.01 88.64 Skin tightness | 5 0.05 88.69 Skin turgor decreased | 1 0.01 88.70 Skin ulcer | 5 0.05 88.75 Skin warm | 1 0.01 88.76 Skull fracture | 1 0.01 88.77 Skull malformation | 1 0.01 88.78 Sleep apnoea syndrome | 6 0.06 88.84 Sleep disorder | 9 0.09 88.93 Sleep disorder due to a general medic.. | 1 0.01 88.94 Sluggishness | 3 0.03 88.97 Small for dates baby | 1 0.01 88.98 Small intestinal haemorrhage | 1 0.01 88.99 Small intestinal obstruction | 3 0.03 89.02 Small intestinal resection | 2 0.02 89.04 Small intestinal stenosis | 2 0.02 89.06 Small intestine carcinoma metastatic | 1 0.01 89.07 Snoring | 1 0.01 89.08 Social phobia | 2 0.02 89.10 Soft tissue mass | 1 0.01 89.11 Somnambulism | 1 0.01 89.12 Somnolence | 22 0.22 89.34 Somnolence neonatal | 1 0.01 89.35 Speech disorder | 14 0.14 89.49 Spinal column stenosis | 5 0.05 89.54 Spinal compression fracture | 4 0.04 89.58 Spinal cord compression | 2 0.02 89.60 Spinal cord disorder | 2 0.02 89.62 Spinal cord injury | 1 0.01 89.63 Spinal decompression | 1 0.01 89.64 Spinal disorder | 4 0.04 89.68 Spinal fracture | 6 0.06 89.74 Spinal fusion surgery | 1 0.01 89.75 Spinal operation | 1 0.01 89.76 Spinal osteoarthritis | 5 0.05 89.81 Spinal pain | 3 0.03 89.84 Splenic rupture | 1 0.01 89.85 Splenic vein thrombosis | 1 0.01 89.86 Splenomegaly | 3 0.03 89.89 Spondylolysis | 1 0.01 89.90 Sporotrichosis | 1 0.01 89.91 Sputum culture positive | 1 0.01 89.92 Sputum discoloured | 3 0.03 89.95 Sputum purulent | 1 0.01 89.96 Squamous cell carcinoma of lung | 1 0.01 89.97 Staphylococcal bacteraemia | 3 0.03 90.00 Staphylococcal infection | 17 0.17 90.17 Staphylococcal sepsis | 1 0.01 90.18 Status epilepticus | 1 0.01 90.19 Stent placement | 1 0.01 90.20 Stevens-Johnson syndrome | 17 0.17 90.37 Stomatitis | 6 0.06 90.43 Streptococcal infection | 4 0.04 90.47 Streptococcal sepsis | 1 0.01 90.48 Streptococcus test positive | 1 0.01 90.49 Stress | 25 0.25 90.74 Stress fracture | 1 0.01 90.75 Stress urinary incontinence | 1 0.01 90.76 Subarachnoid haemorrhage | 2 0.02 90.78 Subcutaneous abscess | 2 0.02 90.80 Subdural haematoma | 4 0.04 90.84 Subileus | 2 0.02 90.86 Sudden death | 2 0.02 90.88 Sudden hearing loss | 1 0.01 90.89 Sudden infant death syndrome | 2 0.02 90.91 Suicidal behaviour | 2 0.02 90.93 Suicidal ideation | 11 0.11 91.04 Suicide attempt | 10 0.10 91.14 Superficial vein prominence | 1 0.01 91.15 Supraventricular extrasystoles | 1 0.01 91.16 Supraventricular tachyarrhythmia | 1 0.01 91.17 Supraventricular tachycardia | 1 0.01 91.18 Surgery | 1 0.01 91.19 Suture rupture | 1 0.01 91.20 Swelling | 17 0.17 91.37 Swelling face | 8 0.08 91.45 Swollen tongue | 2 0.02 91.47 Symblepharon | 1 0.01 91.48 Syncope | 13 0.13 91.61 Synovial cyst | 1 0.01 91.62 Synovial disorder | 1 0.01 91.63 Synovitis | 1 0.01 91.64 Syphilis | 1 0.01 91.65 Systemic inflammatory response syndrome | 1 0.01 91.66 Systemic sclerosis | 1 0.01 91.67 T-cell prolymphocytic leukaemia | 1 0.01 91.68 TELANGIECTASIA | 1 0.01 91.69 THROMBOCYTOPENIA | 1 0.01 91.70 TOXICITY TO VARIOUS AGENTS | 2 0.02 91.72 TRACHEO-OESOPHAGEAL FISTULA | 1 0.01 91.73 TREMOR | 6 0.06 91.79 TRICUSPID VALVE INCOMPETENCE | 1 0.01 91.80 Tachyarrhythmia | 3 0.03 91.83 Tachycardia | 11 0.11 91.94 Tachypnoea | 2 0.02 91.96 Takayasu's arteritis | 1 0.01 91.97 Talipes | 1 0.01 91.98 Tardive dyskinesia | 4 0.04 92.02 Tearfulness | 2 0.02 92.04 Temperature intolerance | 2 0.02 92.06 Temporomandibular joint syndrome | 1 0.01 92.07 Tenderness | 5 0.05 92.12 Tendon calcification | 1 0.01 92.13 Tendon disorder | 4 0.04 92.17 Tendon injury | 4 0.04 92.21 Tendon rupture | 5 0.05 92.26 Tendonitis | 6 0.06 92.32 Tenosynovitis | 1 0.01 92.33 Tension | 2 0.02 92.35 Tension headache | 1 0.01 92.36 Terminal state | 3 0.03 92.39 Testicular atrophy | 1 0.01 92.40 Testicular swelling | 1 0.01 92.41 Therapeutic response decreased | 1 0.01 92.42 Therapeutic response delayed | 1 0.01 92.43 Therapeutic response unexpected | 3 0.03 92.46 Thermal burn | 4 0.04 92.50 Thinking abnormal | 3 0.03 92.53 Thirst | 2 0.02 92.55 Thoracic vertebral fracture | 2 0.02 92.57 Throat cancer | 1 0.01 92.58 Throat irritation | 5 0.05 92.63 Throat lesion | 1 0.01 92.64 Throat tightness | 1 0.01 92.65 Thrombin-antithrombin III complex inc.. | 1 0.01 92.66 Thrombocytopenia | 26 0.26 92.92 Thrombocytosis | 1 0.01 92.93 Thrombophlebitis | 2 0.02 92.95 Thrombophlebitis superficial | 3 0.03 92.98 Thrombosis | 15 0.15 93.13 Thrombosis in device | 1 0.01 93.14 Thrombosis mesenteric vessel | 1 0.01 93.15 Thrombotic thrombocytopenic purpura | 1 0.01 93.16 Thyroid atrophy | 1 0.01 93.17 Thyroid disorder | 4 0.04 93.21 Thyroid function test abnormal | 2 0.02 93.23 Thyroid neoplasm | 1 0.01 93.24 Tinea cruris | 1 0.01 93.25 Tinea pedis | 4 0.04 93.29 Tinnitus | 8 0.08 93.37 Tongue blistering | 1 0.01 93.38 Tongue discolouration | 3 0.03 93.41 Tongue disorder | 1 0.01 93.42 Tongue dry | 1 0.01 93.43 Tongue spasm | 1 0.01 93.44 Tonsillitis | 1 0.01 93.45 Tooth abscess | 4 0.04 93.49 Tooth disorder | 2 0.02 93.51 Tooth fracture | 1 0.01 93.52 Tooth infection | 2 0.02 93.54 Tooth loss | 5 0.05 93.59 Toothache | 5 0.05 93.64 Torsade de pointes | 3 0.03 93.67 Torticollis | 1 0.01 93.68 Toxic epidermal necrolysis | 16 0.16 93.84 Toxicity to various agents | 30 0.30 94.14 Tracheal disorder | 2 0.02 94.16 Tracheitis | 1 0.01 94.17 Transfusion | 1 0.01 94.18 Transient ischaemic attack | 8 0.08 94.26 Transitional cell carcinoma | 1 0.01 94.27 Treatment noncompliance | 2 0.02 94.29 Tremor | 17 0.17 94.46 Tricuspid valve incompetence | 7 0.07 94.53 Tricuspid valve stenosis | 1 0.01 94.54 Trigeminal neuralgia | 1 0.01 94.55 Trismus | 4 0.04 94.59 Troponin increased | 2 0.02 94.61 Tuberculosis | 3 0.03 94.64 Tuberculous pleurisy | 1 0.01 94.65 Tubulointerstitial nephritis | 3 0.03 94.68 Tumour flare | 4 0.04 94.72 Tumour haemorrhage | 1 0.01 94.73 Tumour marker increased | 2 0.02 94.75 Tunnel vision | 1 0.01 94.76 Type 1 diabetes mellitus | 1 0.01 94.77 Type 2 diabetes mellitus | 8 0.08 94.85 URINARY RETENTION | 1 0.01 94.86 Uhthoff's phenomenon | 1 0.01 94.87 Ulcer | 1 0.01 94.88 Ulcer haemorrhage | 2 0.02 94.90 Ulna fracture | 1 0.01 94.91 Ultrasound breast abnormal | 1 0.01 94.92 Umbilical hernia | 1 0.01 94.93 Unevaluable event | 13 0.13 95.06 Unresponsive to stimuli | 8 0.08 95.14 Upper extremity mass | 1 0.01 95.15 Upper gastrointestinal haemorrhage | 3 0.03 95.18 Upper limb fracture | 6 0.06 95.24 Upper respiratory tract congestion | 2 0.02 95.26 Upper respiratory tract infection | 7 0.07 95.33 Upper respiratory tract inflammation | 3 0.03 95.36 Upper-airway cough syndrome | 1 0.01 95.37 Uraemic encephalopathy | 1 0.01 95.38 Urethral dilatation | 1 0.01 95.39 Urinary incontinence | 8 0.08 95.47 Urinary retention | 3 0.03 95.50 Urinary retention postoperative | 1 0.01 95.51 Urinary tract infection | 27 0.27 95.78 Urinary tract infection bacterial | 1 0.01 95.79 Urinary tract infection pseudomonal | 1 0.01 95.80 Urine analysis abnormal | 2 0.02 95.82 Urine bilirubin increased | 1 0.01 95.83 Urine ketone body present | 2 0.02 95.85 Urine odour abnormal | 1 0.01 95.86 Urine output decreased | 6 0.06 95.92 Urine output increased | 2 0.02 95.94 Urosepsis | 1 0.01 95.95 Urticaria | 17 0.17 96.12 Uterine cancer | 2 0.02 96.14 Uterine cervical squamous metaplasia | 1 0.01 96.15 Uterine fibrosis | 1 0.01 96.16 Uterine haemorrhage | 1 0.01 96.17 Uterine leiomyoma | 4 0.04 96.21 Uveitis | 1 0.01 96.22 VASCULAR RESISTANCE SYSTEMIC INCREASED | 1 0.01 96.23 VIIth nerve paralysis | 5 0.05 96.28 Vaccination site cellulitis | 1 0.01 96.29 Vaginal discharge | 2 0.02 96.31 Vaginal haemorrhage | 8 0.08 96.39 Vaginal infection | 1 0.01 96.40 Varices oesophageal | 1 0.01 96.41 Varicose vein | 2 0.02 96.43 Vascular anomaly | 1 0.01 96.44 Vascular graft occlusion | 1 0.01 96.45 Vascular occlusion | 1 0.01 96.46 Vascular rupture | 1 0.01 96.47 Vasodilatation | 2 0.02 96.49 Vasogenic cerebral oedema | 2 0.02 96.51 Vein discolouration | 1 0.01 96.52 Vein disorder | 4 0.04 96.56 Vena cava injury | 1 0.01 96.57 Vena cava thrombosis | 1 0.01 96.58 Venous injury | 1 0.01 96.59 Venous insufficiency | 4 0.04 96.63 Venous occlusion | 1 0.01 96.64 Venous thrombosis limb | 1 0.01 96.65 Ventricular arrhythmia | 1 0.01 96.66 Ventricular extrasystoles | 3 0.03 96.69 Ventricular fibrillation | 3 0.03 96.72 Ventricular hypertrophy | 4 0.04 96.76 Ventricular septal defect | 3 0.03 96.79 Ventricular tachycardia | 5 0.05 96.84 Vertigo | 11 0.11 96.95 Vestibulitis | 1 0.01 96.96 Viraemia | 1 0.01 96.97 Viral infection | 5 0.05 97.02 Viral load increased | 2 0.02 97.04 Viral pharyngitis | 2 0.02 97.06 Viral upper respiratory tract infection | 1 0.01 97.07 Visceral leishmaniasis | 1 0.01 97.08 Vision blurred | 16 0.16 97.24 Visual acuity reduced | 5 0.05 97.29 Visual impairment | 12 0.12 97.41 Vitamin B complex deficiency | 1 0.01 97.42 Vitamin B12 decreased | 2 0.02 97.44 Vitamin B12 deficiency | 1 0.01 97.45 Vitamin D decreased | 2 0.02 97.47 Vitamin D deficiency | 2 0.02 97.49 Vitreous floaters | 1 0.01 97.50 Vitreous haemorrhage | 1 0.01 97.51 Vocal cord disorder | 1 0.01 97.52 Volume blood decreased | 1 0.01 97.53 Vomiting | 67 0.67 98.20 Vomiting in pregnancy | 1 0.01 98.21 Vulval ulceration | 1 0.01 98.22 Vulvovaginal pain | 1 0.01 98.23 Walking aid user | 1 0.01 98.24 Walking disability | 1 0.01 98.25 Weaning failure | 1 0.01 98.26 Weight abnormal | 1 0.01 98.27 Weight decreased | 56 0.56 98.83 Weight fluctuation | 1 0.01 98.84 Weight increased | 32 0.32 99.16 Wheezing | 8 0.08 99.24 White blood cell count abnormal | 1 0.01 99.25 White blood cell count decreased | 27 0.27 99.52 White blood cell count increased | 20 0.20 99.72 White blood cells urine positive | 1 0.01 99.73 Withdrawal syndrome | 3 0.03 99.76 Wound | 5 0.05 99.81 Wound dehiscence | 3 0.03 99.84 Wound drainage | 1 0.01 99.85 Wound haemorrhage | 2 0.02 99.87 Wound infection | 3 0.03 99.90 Wound secretion | 1 0.01 99.91 Wrist fracture | 2 0.02 99.93 Wrong drug administered | 2 0.02 99.95 Wrong technique in drug usage process | 1 0.01 99.96 Xerosis | 2 0.02 99.98 Yellow skin | 1 0.01 99.99 ZYGOMYCOSIS | 1 0.01 100.00 ----------------------------------------+----------------------------------- Total | 10,000 100.00 by Jean Roth , jroth@nber.org , 7 Apr 2017